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Summary
Embedded systems are being widely used in health care related applications.
They are used in imaging systems, regenerative medicine and tissue engineering,
rehabilitation medicine, continuous monitoring and delivery of drugs, personalized
medicine, detection of diseases and early stage diagnostics, and so on.
During the design of an embedded system for a specific application, there can be
several constraints or requirements. The system might be required to carry out
certain complex tasks; it might need to operate in real-time to meet timing dead-
lines; the system might need to consume very low power; the system might have
restrictions on the dimension and weights. So, designing an embedded system can
be very challenging and complicated depending on the actual applications and it is
necessary to follow certain design procedures or design methodologies in order to
guarantee that the designed system would meet all the functional or non-functional
requirements of the application. The thesis focuses on designing embedded systems
for five biomedical applications and each design follows a proper embedded system
design methodology. The design of these embedded systems goes from ready-to-use
to custom, then from custom to standard.
The first project is in Chapter Two and it is about designing an electrical and me-
chanical signal generation system for cell stimulation and monitoring application.
The designed embedded system is based on a ready-to-use Raspberry Pi (RPi)
board and only an external custom circuit board is designed for the project. So,
the design of the system is very easy and not much extra effort is needed in terms
of hardware design. However, the RPi contains many hardware resources that are
not required for the project and they contribute to an excessive amount of power
consumption. The board is also not flexible as its hardware design is fixed. So,
in the following applications presented in Chapter Three, Four and Five, embed-
ded systems are custom designed in order to achieve flexibility and optimization
in hardware, reduction in area, optimization in performance, reduction in cost and
also in power consumption.
In the Chapter Three, a custom designed wearable, wireless, low-power surface
EMG system is presented. The main objective of the system is to acquire surface
EMG signals from muscles of the patient for a long time of up to several days. The
commercially available surface EMG devices could carry out maximum 12-hour
iii
continuous EMG signal acquisition and are not suitable for long-term monitoring.
So, a power efficient, wearable, wireless embedded system is designed for this pur-
pose. The design of the system has followed the successive refinement model and
three prototypes are designed. The measurement results show that the designed
system could carry out continuous signal acquisition for 32 to 61 hours with a coin
battery of 450 mAh capacity.
In the Chapter Four, a custom designed electrochemical biosensing platform for
anesthesia monitoring and delivery is presented. The continuous monitoring and
correct delivery of anesthesia is important as the anesthesia is a very powerful and
dangerous drug that could result in serious safety problems if not monitored or de-
livered correctly to the patient. So, an embedded biosensing platform is presented
in this chapter. The design of the system has strictly followed the hardware and
software design methodology and relevant experiments are carried out on Parac-
etamol and Propofol using different electrochemical techniques.
In Chapter Five, a custom designed memristive biosensing platform for early stage
cancer diagnostics is presented. Memristive biosensors are ideal candidates for the
cancer detection due to their ultra-high sensitivity. However, commercially avail-
able electronic platforms for memristive biosensors are probe stations and parameter
analyzers. These devices are very bulky and the test would take very long time.
Therefore, a portable, easy-to-use embedded biosensing platform is required for the
measurement and also for automatic data processing. So, by following hardware
and software design methodology, an embedded system is designed and relevant
tests are carried out for the Prostate Specific Antigen (PSA) detection. The test
results confirm the functionality of the system and the correct design process.
After the design of the custom electrochemical and memristive biosensing plat-
forms, the two hardware architectures are compared with each other and several
similarities are found. For example, in both platforms, the voltage signals coming
from the biosensor analog front end are processed by the Analog to Digital Con-
version blocks, then analyzed by the data post processing blocks. Both platforms
are controlled by similar Graphical User Interfaces (GUI). So, these hardware ar-
chitectures can be standardized and in the final application in Chapter Six, the
design target has switched from custom to standard and a general purpose embed-
ded platform that supports various types of biosensors is presented. The system is
validated with three types of electronic biosensors such as electrochemical, mem-
ristive and ion-sensitive biosensors and its generality, the design concept and the
design approach are confirmed through experimental results.
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Chapter 1
Introduction and Thesis aims
1.1 What is an Embedded System
Ever since the first-generation computer is invented, the computer technology
has evolved substantially. There have been the year of vacuum tube, the creation
of first transistor and then the integrated circuit before the invention of the micro-
processor in 1970. The invention of the microprocessor has been the main reason
for the invention of the personal computer (PC) and also for graphical user inter-
face(GUI) development. In the meanwhile, the microprocessor invention has also
led the development of an another type of computer system, the task-specific com-
puter system, also called an Embedded System [1].
1.1.1 Definition
Embedded system is a microprocessor or rather a micro-controller based sys-
tem that is composed of hardware and software designed for specific purposes or
tasks. Its definition can be more clear by comparing it with the PCs. The PC is
a general-purpose platform that can execute a generic type of operations that user
wants. For example, the PC can be a music player; it can be a text editor; it can
be a calculator; it can be an audio or video recorder; it can be a data transmitter
or data logger; it can be an image visualizer and editor, etc [2].
An embedded system receives inputs from the user, processes it and carries out the
specific operations. A possible structure of an embedded system can be as shown
in Figure 1.1.
So, an embedded system can contain inputs to receive commands or signals from
external environment. It contains a real-time operating system (RTOS) that con-
tinuously executes the software loaded inside the hardware and the RTOS is re-
sponsible for carrying out different operations based on the inputs. It can contain
outputs that can be processed data, specific signals or commands, etc. It can also
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Embedded System 
Software
Hardware
Inputs Outputs
Connection to
other devices
(Possible user
interface)
Figure 1.1: Block representation of an embedded system.
contain a user interface in order to receive control commands from the user. It can
also be connected to other devices for other purposes.
Generally, an embedded system hardware can contain a microprocessor, a memory
and peripherals. The microprocessor executes the operations defined by the soft-
ware written inside the memory. The memory can be used for storing the software
and also the data. The peripherals can be used for specific aims such as providing
clocks, generating signals, processing signals, etc. Some examples of the embedded
systems include:micro-controller, expended micro-controller, microprocessor based
embedded systems, board based embedded systems, and so on [3].
As mentioned earlier, the embedded system is dedicated to limited number of oper-
ations. For example, a washing machine can contain a microprocessor or a micro-
controller based embedded system for starting and stopping the washing, setting up
the temperature, setting up the rotation speed, selecting the operation type and so
on. But a washing machine cannot execute other generic types of operations, such
as heating a food, capturing a picture or displaying an image, etc. A car washer
can be based on an embedded system that is dedicated to selecting the water speed,
water temperature, washing control, etc. So, these examples well explain that an
embedded system is designed for a specific task or set of tasks and it cannot work
as a general-purpose platform like a PC.
1.1.2 Embedded System Types
The embedded systems can be divided into three groups based on the perfor-
mance:
• Sophisticated
• Medium scale
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• Small scale
According to the functionality requirement and performance, they can be divided
into following groups:
• Stand alone
• Real-time
• Mobile
• Networked
Sophisticated embedded systems
These are embedded systems with 32 or 64-bit microprocessors or micro-controllers
and the complexity of software and hardware are very high. They contain enormous
hardware resources and are dedicated to cutting edge applications where scalable,
parallel and configurable processors are needed.
Medium scale embedded systems
These embedded systems usually contain 16-bit or 32 bit microprocessors or
micro-controllers with external ROM and RAM so that they can carry out medium
complexity jobs. They support high level programming languages such as Java, C,
C++, Visual C++, RTOS, etc.
Small scale embedded systems
Such systems include 8-bit or 16-bit microprocessors or micro-controllers and
they are dedicated to simple tasks. They can be used for developing battery powered
electronic systems.
Stand alone embedded systems
These types of embedded systems are electronic systems that don’t need a host
computer and can carryout defined operations by themselves. They can accept
analog or digital input signals, then process these signals and finally transmit these
signals to other peripherals for display or for further post-processing purposes.
They can also execute tasks according to the internal software without having
input signals. Some examples can be the microwave oven, washing machine, etc.
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Real-time embedded systems
From the name, it can inferred that these types of embedded systems are those
that can carryout operations within a dedicated time and they usually contain
high performance micro-controllers or microprocessors with complex peripheral re-
sources. Examples can be the traffic surveillance systems, video processing plat-
forms, etc.
Mobile embedded systems
These types of embedded systems are extensively used in portable devices, such
as mobile phones, smart phones, digital cameras, etc.
Networked embedded systems
These are electronic systems dedicated to the networking applications. They
can provide access to network resources and the network can be internet or LAN
or WAN.
1.1.3 Advantages of Embedded Systems
Embedded systems have the following advantages [2]:
• They can replace the discrete logic-based circuits thanks to the flexibility of
their internal software.
• They can provide functional updates without changing the system hardware.
• They can provide easy maintenance upgrades.
• They can provide improved mechanical stability and performance.
• They can provide better intellectual property rights protection.
• They can replace the traditional analog circuits.
1.1.4 Challenges in Embedded Systems
Embedded systems are specific purpose platforms that carry out a single or a
set of operations. So, they usually have very limited hardware resources. This can
result in performance constraints, real-time constraints, resource constrains and
power consumption constraints. They are also sensitive to the cost and the price of
a single component can affect the cost of the overall system. The software failure
is more common than other general purpose platforms and the development of
software needs specific debugging circuitry, software development environment and
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tools. So, these challenges should be taken into consideration when an embedded
system is designed for a given application [3].
1.2 Embedded System Design Process
When designing embedded systems, an individual designer or design team usu-
ally follow some processes or approaches in order to carry out the design in a
systematic way. A general steps that are included in the embedded system design
process are shown in Figure 1.2.
As it can be seen from the Figure 1.2, the design process starts with the require-
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Figure 1.2: Major steps involved in the embedded system design process [4]
ments that indicate what is needed as a final goal. Then there is the specification
that describes in details how the system behaves. Then there is the architecture
design step that decides the system architecture in terms of blocks. Then the hard-
ware and software components are analyzed and selected. Once the components
are chosen, then they are designed in more details and integrated into the system
in the final step.
The design process can follow the top-down approach or the bottom-up approach.
In the top-down approach, the design is started from the most abstract level of the
system and then goes to the concrete details of the system. While the bottom-up
approach is exactly opposite and the design starts with known components. Then
the functionality and specification are decided according to the design. Then it
goes to the architecture level and so on. This approach is necessary when there is
not enough information about the outcomes of the design process and also about
the possible functionality that the final system can have at the end [4].
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1.2.1 Requirements
Before the embedded system design process is started, it is important to know
what should be the final goal of the design, such as the functionality that the
system should have and the operations it should carry out. These information can
be collected based on the needs of the user.
Besides having the basic functional requirements of the system, it is also important
to have the nonfunctional requirements that include:
• Performance: The performance of the system can affect the usability and
also its final cost. it is related to whether an embedded system can perform
a required operation within a given time.
• Cost: The cost is one of the major consideration in the design. It contains two
types of costs: 1) the manufacturing cost that is composed of component and
assembly cost 2) nonrecurring engineering cost that includes the personnel
and other costs of the design.
• Physical size and weight: The physical dimension and weight of the embedded
system are dependent on the application and they affect the usability of the
system. Both are important factors especially in the design of an implantable
or wearable embedded systems.
• Power consumption: In the battery-powered embedded systems, the power
consumption is an an important factor to consider as it directly decides the
operational lifetime of the system.
1.2.2 Specification
Specification is the bridge between the requirements and architecture of the
system. it is the detailed description of the user requirements and it helps the
designers understand exactly what they are building. Specifications indicate clearly
the type of inputs and outputs of the system, the exact operations to be carried
out to meet user requirements, other relevant operations needed to keep the system
running properly.
1.2.3 Architecture
Although the specifications indicate what tasks an embedded system does, they
don’t indicate how the embedded system carries out these tasks. The architecture
design can indicate how the embedded system carries out operations and define
what types of functional blocks are needed in order to carry out the specified op-
erations. It also indicates how these functional blocks interact with each other and
exchange data or information between them.
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The architecture design includes both the hardware architecture and software ar-
chitecture designs. The hardware architecture indicates what kind of hardware is
needed for a specific operation, while the software architecture indicates how the
operations are executed in the hardware architecture.
The functional and non-functional requirements should be both met during the ar-
chitectural design. Besides all the functional requirements are present in the block
diagram of the architecture, the other requirements such as power, performance,
cost, speed and other constraints should also be taken into account during the
architectural description. This can be done by considering the properties of the
components in the diagram [4].
1.2.4 Hardware and Software Components Design
However, the architectural design is still in the abstract level and it does not
indicate the exact types of components that are required for the design. These
components are built in details in the hardware and software components design
step. During the hardware components design, a proper ready-to-use hardware is
selected or a hardware component is designed in order to meet the architecture
requirement and specifications. During the software components design, the soft-
ware module is selected or is developed for the correct operation and functional
requirements of the software architecture.
1.2.5 System Integration
After the hardware and software components are ready, they need to be inte-
grated to build a working embedded system. it is not just placing the software and
hardware components together. But there is the need to guarantee that the hard-
ware design components are able to carry out the software operations, as well as
the software design components can control correctly the hardware resources. Usu-
ally there are the compatibility issues between the hardware and software, as well
as hardware and software bugs. These problems can be addressed in component
design phase by carrying out independent debug and test operations on individual
hardware and software components [4].
1.3 Design Methodology
As it can be seen that, the embedded system design process includes several
steps. When designing complex and sophisticated embedded systems, the func-
tional specifications can be very complex and these specifications should also com-
ply with other requirements on performance, cost, power, etc. So, there is a need
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to follow some design flows or methodologies during the design of large systems.
The design process is important because it is related to the delivery of the em-
bedded system products. When designing simple embedded systems, following the
previously mentioned general design process maybe feasible. But when it is a com-
plex embedded system, many teams might involve in the process and it is important
for them to be explicit and be well-organized and coordinated during the design
process.
Besides the delivery of the useful product, the design process also aims at function-
ality, performance and power of the system. Besides that, the design process also
focuses on other goals that include the time-to-market, design cost and quality.
However, the design process changes over time. It can change due to internal or
external forces. Customers, the requirements, products and also the available com-
ponents can change. Therefore, it is necessary to follow a good design methodology
in order to build an embedded system that works as expected. This is extremely
important in the health care, aerospace and automotive systems as serious safety
problems can arise due to the bugs in the design process [4].
The common design methodologies include:
• waterfall model
• spiral model
• successive refinement model
• hardware/software design model, also called the concurrent model
1.3.1 Waterfall Model
The waterfall model is initially created for the software development purposes.
It follows a top-down approach. In the requirements step, the basic characteristics
of the system are analyzed. In the architecture step, the functionality of the system
is decomposed into major components. In the coding step, the detailed software
components are written and integrated. In the testing step, the software bugs are
addressed and fixed. In the maintenance step, the software system is deployed in
fields and is regularly updated. The waterfall model assumes that the designer has
well understanding in the details of the system in the early stage of the design.
However, this is not realistic during the design of complicated systems, because it
is not possible to know all the details of the system. Besides that, there is limited
feedback from lower design layer to higher abstract layer as the design follows one-
way work and information flow.
A typical waterfall model in the software development is shown in Figure 1.3.
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Figure 1.3: Waterfall model methodology in software development [4].
1.3.2 Spiral Model
In the spiral model, multiple versions of the system are developed. Starting
from simple versions of the systems at the beginning, designers can optimize and
improve their intuitions and experiences with the system. Then as the design
process continues, more robust and sophisticated systems can be built. Each level
of design includes requirements, design and testing phases. This model is more
preferred than the waterfall model, as after several iterations of the design, it is
possible to include all the functional details and achieve the goal of designing of
a complete system. In the cases when there is a strict design time requirement,
the spiral model may not be very appropriate as it might take more time with the
design process when the systems get more complicated with more spirals.
The Figure 1.4 demonstrates the flow of the spiral model.
   	

 !"
#$%!$!
&’( )
*"! )
+, ! , $
-./012345
67897:;<:;9;9678<=:;>?
@A"!BC,"DE!A
@F$C$,!’ 
G !,EB"A"!B
H %, $(B"A"!
@A"!BECB$A$E
IJKLMN
OJPQLRJSJNTK
UJKT
V’!’!AF
-./01234W
>87:;<:;9;9678<?
XYZ[\]^ _‘aYZZbc‘dYeY_f[g[Z[h^ ‘_gi]gg‘j]‘ddkiggkYdigY_limh‘XYm[Zg‘nY
inmYg‘o]XY_Zgi]Xi]Xk‘d‘gkY_Zi_Y_Yiag[]\i\i[]Zg[gb
p[\o_Yqbr[moZg_igYZi]imgY_]ig[eYh‘XYm‘lZ‘lgdi_YXYeYm‘^hY]gaimYXgkY
stuvwxyz{|x}~‘Ybk[mYgkYdigY_limh‘XYmiZZohYZgkiggkYZZgYh[Zno[mg
‘]aY[][gZY]g[_YgfgkYZ^[_imh‘XYmiZZohYZgkigZYeY_imeY_Z[‘]Z‘lgkYZZgYh
Figure 1.4: Spiral model design methodology [4].
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1.3.3 Successive Refinement Model
In the successive refinement model, the system is built several times. An initial
prototype system is designed, then is further refined by building successive models
of the system. This methodology can be used when the designer is unfamiliar with
the application environment. By building an initial system, one can find out what
architecture and design techniques can be used, can figure out the existing problems
in each step of the design and can also understand the responses of the system for
the given inputs. In the design of the next version of the system, the designer can
address these problems and optimize the system.
The typical design flow of a successive refinement model is shown in Figure 1.6. 	
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Figure 1.5: Successive refinement model design methodology [4].
1.3.4 Concurrent Model
The design of embedded systems include both the hardware design and software
design. The software/hardware design model, also called the concurrent model is a
design methodology where the hardware and software design are considered simul-
taneously during the design process. he Figure 1.6 shows the involved steps in the
concurrent model. The requirements and specification, architecture steps consider
the hardware and software in parallel. In the system integration and test stages,
again both the hardware and software are considered together. In the design stage
where the detailed hardware and software components are designed, they can be
carried out independently.
This design methodology is extremely useful when designing a large complex sys-
tem. The development teams can work in parallel while reducing the design time.
It can also be very useful to keep track of the complete design flow and optimize it.
The concurrent model includes several elements:
• Cross-functional teams
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Figure 1.6: Concurrent engineering model design methodology [4].
• Concurrent product realization
• Incremental information sharing
• Integrated project management
1.4 Embedded Systems in Biomedical Applica-
tions
Embedded systems are being widely used in biomedical applications and are
playing important roles in health care industry. The recent advances in embedded
systems technology are transforming the health care solutions rapidly and making
it possible to design smaller, wearable, smarter and connected medical devices in
medical applications. During the development of these medical devices, the embed-
ded systems have been part of them and one of the reasons for the improvement
in the technology [5]. These medical devices are more portable and smaller. Smart
devices like glucose monitors and blood pressure monitors are giving the patients
the possibility to continuously monitor their health conditions at home without
going to the hospitals [6] [7]. Furthermore, shrinking in size makes it possible for
medical devices to be implanted inside the patients for long term monitoring [8].
The thesis focuses on the application of embedded systems in the following fields:
• regenerative medicine
• therapeutic drug monitoring
• cancer diagnostics
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• rehabilitation therapy
The decision of targeting these four different applications was due to their huge
market potential and their important roles in the health care. They are sufficiently
broad to give the possibility of exploiting the several possible solutions given by
embedded systems, challenging diversified implementation methods, with the goal
of demonstrating the effectiveness of the use of embedded solutions for these im-
portant application domains.
1.4.1 Embedded Systems in Regenerative Medicine
Regenerative medicine is being recognized as an important research field that
could revolutionize the patient care in 21st century. There are great scientific, pub-
lic and commercial interests in the massive health care markets, such as chronic
metabolic diseases or neurological conditions, cardiovascular diseases which are po-
tentially addressed by regenerative medicine [9]. According to the report from
Markets and Markets website (https://www.marketsandmarkets.com), the Regen-
erative Medicine Market is expected to reach USD 38.7 billion by 2024 from USD
13.3 billion in 2019.
In regenerative medicine, during the culturing of the cells in vitro, the ambient
environment of the cell plays critical role in the growing of the cells, as the cells
are instructed by various kinds of stimuli that simulate the condition of the cells
in vivo. The stimuli can be chemical, mechanical or electrical. The electrical and
mechanical stimuli play important role in the cardiac related applications [10].
The embedded systems can be ideal candidates for the design of electrical and
mechanical stimulation signal generators and several studies have been done on
the development of electrical and mechanical bioreactors for stem cell stimulation.
Mantero et al. have developed an electrical and mechanical bioreactor for skeletal
muscles [11]. Pavesi et al. have developed a cell culture platform for cardiac tis-
sue application [10]. However, these systems have large dimensions, high costs, low
output load current and are not flexible or customizable in order to fit requirements
of a specific stimulation application. Besides that, these systems lack the capability
of monitoring the status of the stimulated cells. So, there is the need to develop
an easy-to-use, low-cost, portable, flexible and accurate electrochemical stimulation
system with monitoring capability for the cell stimulation applications.
1.4.2 Embedded Systems in Rehabilitation Therapy
Rehabilitation therapy aims at regaining or restoring the neurocognitive func-
tions that are lost or diminished in patients that have suffered from neurological
accidents. The physiotheraphy market is expected to reach USD 165.73 billion by
12
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2023 according to the market research report by IndustryARC.
Embedded systems are playing important roles in developing instruments for the
rehabilitation therapy. Such instruments can be used for monitoring the movement
of the patients, activity of their brain, stimulating the muscles of the patients as
well as assisting them with their movements.
During the rehabilitation therapy, clinicians and researchers record the muscle ac-
tivities of the patients and analyze the defects in their movements, then address
proper methods for curing them. One of the commonly used embedded devices for
the monitoring process are the EMG devices, such as COMETA, FreeEMG, Con-
sensus, Shimmer, etc. These devices support multy-channel acquisition and also a
continuous signal monitoring of up to 12 hours.
In some cases, the clinicians might need a long-term monitoring of the patient
that require acquisitions of one to several days. The available EMG devices in the
market cannot fulfill this long-term acquisition requirement. Furthermore, another
factor that limits the usage of these devices is the high cost. So, there is the need
to design a low power, low cost embedded system for the EMG monitoring.
1.4.3 Embedded Systems in Therapeutic Drug Monitoring
The therapeutic drug monitoring (TDM) is a branch of clinical pharmacology
and clinical chemistry. It specializes in measuring concentration of drugs in blood
[12]. The aim of the TDM is to improve the patient care through the adjustment
of the dose. It is based on a priori clinical,demographic and pharmacogenetic in-
formation, and/or on the posteriori measurement of blood concentrations of drugs
(pk/pd monitoring) [13].
According to the market report from Markets and Markets website, the therapeutic
drug monitoring market is expected to reach USD 1.63 billion by 2023 from USD
1.16 billion in 2017.
Medical devices based on embedded systems are being widely used in the TDM.
For example, immunoassay analyzers and mass spectrometry are widely used in
centralized laboratories for TDM. Continuous-flow anaesthetic machine, bispectral
index monitors, heart rate and blood pressure monitors are used by anesthesiolo-
gists during surgeries for continuous monitoring and anesthesia delivery.
In anesthesia delivery, anesthesiologists deliver the anesthesia to the patients ac-
cording to specific delivery models that consider parameters such as age, weight,
sex and height, as well as the Bispectral index and blood pressure of the patient.
However, due to the patient variability and the metabolic process, it is difficult
to accurately decide the amount of dose that needs to be delivered to the patient
during surgery and excessive or insufficient amount of dose could produce severe
problems to the patients.
So, an embedded system for continuous monitoring and delivery of anesthesia is
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needed in order that the correct amount of anesthesia can be delivered to the patient
during the surgery.
1.4.4 Embedded Systems in Cancer Diagnostics
According to the released reliable data about the global epidemiology of cancer
by World Health Organization (WHO), cancer is listed as of the most common
diseases. There are as many as 14 million new cases and around 8.8 million deaths
around the globe due to the cancer.
Cancer diagnostics aims at detection of cancer and the early stage cancer detection
is very importance in cancer diagnostics. More treatment options can be adopted
when the cancer is in its early stage.
In recent studies, memristive biosensors are being used as a new way of detection
of the cancer and have demonstrated ultra-high sensitivity in prostate cancer de-
tection. These biosensors are used together with commercial probe stations and
parameter analyzers [14].
However, although the memristive biosensors exhibit the high sensitivity for cancer
detection, the measurement setup is very bulky, hard to use and the measurement
takes too long time. Besides that, the processing of the measurement data is all
manual and is processed separately. This adds further delays to the availability of
the detection results. These problems could be addressed by designing an embedded
system platform that hosts the memristive biosensors, carries out the measurement
and data processing automatically. So, there is the need to develop an embedded
biosensing platform that is easy to use, programmable, portable, has low cost and
low power.
1.5 Research Challenges
As mentioned earlier, the thesis focuses on designing embedded systems for
biomedical applications in different areas listed above. Due to the huge diversity
of these areas, a single embedded system might not be able to meet all the require-
ments and specifications of these applications. So, a specific embedded system has
to be designed in each application scenario.
Furthermore, in each application, the embedded systems are complex and the de-
sign process includes several teams to collaborate. Each design project may have
different requirements and specifications, different design and test teams, different
completion cycles. Last but not least, some of these designs have to be carried out
in parallel.
However, the design of these systems cannot be random, but it has to follow proper
design approaches or methodologies. Through the right design methodology, at the
end of the design, one can guarantee the reliability and usability of the system and
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the designed system might be able to meet all the requirements and specifications
of the target application. The collaboration among different teams can be managed
efficiently and design time could be optimized.
So, the key challenge is how to choose a proper design methodology or approach in
order to design an embedded system for a given application. The selection of the
methodology could depend on the complexity of the embedded system, amount of
available information from the possible application, requirements and specifications
of the biomedical application, experience of the design teams, affordable cost for
the development, time to market and lifetime of the embedded system, available
resources and technology for the design and production of the system, maintenance
and upgrading requirements, etc.
1.6 Thesis Outline
In this chapter, the concept of the embedded system is introduced. The common
types of embedded systems are analyzed. The design process is explained and
several design methodologies are presented. The main goal of the thesis is to
demonstrate how these design methodologies are applied successfully in designing
complex systems for the biomedical applications and relevant results are presented
and discussed.
The following chapters of the thesis are organized as follows:
• In Chapter Two, the state-of-the-art in regenerative medicine and tissue engi-
neering is introduced. Then the challenges and research goals are presented,
followed by the analysis of the project and selection of the design methodol-
ogy. Then the detailed steps of the design approach are explained. Finally
the test results are presented and discussed.
• In Chapter Three, a wearable wireless low power surface EMG system is
presented. The system is implemented using the successive refinement model
and relevant results are presented.
• In Chapter Four, an electrochemical sensing platform for continuous monitor-
ing of anesthesia is presented. The design process of the system has followed
the hardware and software design model and several electrochemical experi-
ments have been carried out in order to validate the design of the system.
• Chapter Five is about a novel point-of-care memristive biosensing platform
for cancer detection. The system is designed using the hardware and software
design model and test results related to the measurement of Prostate Specific
Antigen are presented.
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• Chapter Six presents a general purpose interface bus system that supports any
type of electronic biosensors and provides a interface bus standard. In this
design, the hardware and software design model is used. For the validation of
the generality of the system, three types of electronic biosensors are designed
and relevant tests are presented.
• Chapter Seven is the conclusion of the whole thesis and it presents the future
work.
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Chapter 2
Electromechanical Bioreactor
System Design
2.1 Introduction
2.1.1 Regenerative Medicine
Regenerative medicine is one of the new disruptive technologies that are at-
tracting more focus in recent years. It includes the tissue engineering, biomedical
engineering techniques, gene therapy, cell therapies and also other treatments in-
volving biology, pharmaceuticals and devices. The main aim of the regenerative
medicine is to replace or regenerate the tissues, human cells or organs for the pa-
tients that have undergone some diseases or injuries that have caused the permanent
damage of their tissues or organs [15].This can help with therapeutic treatments
where the current methods are inapplicable.
In the regenerative medicine, the cell therapies and tissue engineering enable the
delivery of safe, consistent and efficient therapy. The human body can be mod-
eled as a complex micro-fluidic system which can regenerate or repair its organs
or tissues through stem cells which can be found in those organs or tissues. The
regeneration and repairing is done through evolution of the stem cells, so the con-
tribution of stem cells for the regeneration medicine is vital [16].
2.1.2 Stem Cell Differentiation
In the beginning of 19th century, scientists have discovered that the different
types of blood cells in the human body were originated from a particular cell, called
’stem cell’. Becker et al. (1963) discovered that these stem cells had the capability
of self-renewal and differentiation into various cell lineages. Under certain physi-
ological conditions, with the right stimulation signal, these stem cells can convert
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into specific cells of the body, such as cardiac cells, marvel cells, liver cells, tandem
cells and so on.
The physiological conditions are created using scaffolds. Scaffolds are special me-
chanical structures with biodegradable materials and they can host the stem cells,
can interact with the stem cells and facilitate cell attachment allowing great struc-
tural biomimictry [17]. The scaffolds are similar to the extra-cellular matrix which
exists in all mammalian organs and tissues [18].
On the other hand, the biofunctional stimulation signals can be generated through
signal generation units and are applied to the scaffolds on which the stem cells are
immobilized or tethered. So, the communication between the extra-cellular envi-
ronment and stem cells can be modulated through scaffolds [19]. Therefore, the
key challenges are to design engineered scaffolds and electronic systems that can
generate the right stimulation signals.
Tendon injury is common among elderly people and athletes. One to way to cure the
injury is to use healthy tendon cells to replace the damaged tendon tissues. How-
ever, these tendon cells come from the donation, and are very limited in amount.
Tendon tissue engineering has paved the path to culture new tendon cells in vitro
using specially designed tendon scaffolds [20].
2.1.3 Research Objective
The objective is to design a system that generates stimulation signals and also
hosts stem cells. As the natural functions of the tendon require mechanical stim-
ulation for the stem cells, the system has to be capable of generating mechanical
stimulation. Furthermore, if the system generates also electrical signals, then the
system can be used for the cardiac tissue engineering, where the hosted stem cells
are differentiated into cardiac cells through applied electrical and mechanical sig-
nals. Besides that, the system has to have a low cost, be robust and portable.
Besides that, there is the need to keep the system running continuously for several
days and also a continuous monitoring of the cells might be necessary. In the me-
chanical signal generation, a stepper motor is adopted. So, it is also necessary to
guarantee a safety operational condition for the motor. Therefore, the system has
to perform tasks in real-time for the monitoring and motor control.
2.2 Project Analysis
As it is stated in the previous section, the aim is to design an electronic system
for cell stimulation and monitoring. Electrical and mechanical stimulation signals
should be generated from the system and the platform has to be able to carry out
real-time monitoring. However, it is not yet clear how the electrical and mechanical
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stimulation effects the cells and how the cells change. So, it is preferred to have an
initial prototype of the system in order to have some feedback regarding the sys-
tem requirements and validate the design concept. Then, in the next version of the
system, the possibly encountered problems can be addressed. Besides that, further
functional requirements would be added to the system during the design and test
steps. So, the successive refinement model is suitable for the design process of the
system.
2.3 Model Implementation
This section describes how the design steps of the successive refinement model
are implemented. After the first complete cycle that includes steps from require-
ments to the system integration. The first prototype of the system is complete.
After the test and validation, the design techniques, hardware and software blocks
are optimized and refined in the next cycle of the system design.
2.3.1 Requirements
The functional requirements of the electromechanical stimulation and monitor-
ing system are following:
• Voltage signal should be generated for the electrical stimulation.
• The voltage should be AC type with an amplitude in the range of 0.2 to 5V.
• The voltage signal should not have an DC offset.
• The voltage should be a square wave with a frequency of 1 Hz for human cells
and 3 Hz for mice, and a pulse duration of 1-3 ms.
• There is only one stretching motor used for the mechanical signal generation.
• It would be great to monitor the stem cells in real-time during the stimulation.
• Safety operation should be guaranteed for the motor as it is tied to the scaf-
fold.
The non-functional requirements can be as following:
• The system should monitor the cells in real-time.
• The system should be cost-effective.
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• The system should be portable, should have a proper physical dimension and
moderate weight.
• The system should be reliable and should operate as expected.
2.3.2 Specification
After the requirements are written, the next step is to specify in more details
the needs of the actual application and also to translate the needs into the de-
sign requirements of the system. For the electrical stimulation, a voltage signal is
needed, so there should be a functional unit that can generate the voltage signals.
Besides that, the voltage signal is an AC type square wave voltage signal with a
fixed frequency, with a variable amplitude and pulse duration. So, the functional
block of the electrical stimulation should be able to generate a voltage signal that
can be tuned. The output of the voltage signal is without a DC offset, so the func-
tional unit should be able to generate an AC voltage signal without an offset. The
voltage signal has a fixed frequency, so the timing requirement should be respected
when the signal is generated.
The mechanical stimulation signal comes from the motor, so there should be a
functional block that can drive and control the single motor according to the needs
of the stimulation. The motor is connected to the scaffold, so it is important to
have a safe operating status of the motor and its movement should be precisely
controlled.
The monitoring of the cells in real-time is also part of the goal of the system. So,
there should be a functional block with integrated camera for the monitoring. It
should also respect the real-time monitoring requirement, so this functional unit
should have a fast image processing capability and a display or monitor is needed.
2.3.3 Architecture
After the specifications, the next step is to design the architecture of the system.
As it is stated earlier, there is the need to have a real-time monitoring capability.
So, the system should be a real-time embedded system with high performance mi-
croprocessors or micro-controllers. The design of the architecture is composed of
two parts: hardware architecture and software architecture.
The hardware architecture has to contain functional blocks that generate electri-
cal signals, drive and control motors, monitor cells in real-time. Besides that,
there has to be a central control block that takes control of all other hardware
blocks and interacts with the user input. So, a possible hardware architecture with
these functional blocks can be as depicted in figure 2.1. The software architecture
should contain the functional blocks that carry out the correct operations, such as
20
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Display
Voltage
Generation
Amplitude
Control
Electrical Stimulation Unit
Motor
Controller
Motor
Mechanical Stimulation
CPU Camera
Microscope
Real-time monitoringCentral Control
Rotational
Encoder
Decoder
Figure 2.1: Block representation of the hardware architecture of the system.
generation of expected voltage signals, precise movement of the motor, real-time
monitoring of cells and correct interaction with the user. The software architecture
can be as depicted in figure 2.2.
Electrical
Stimulation
Control
Mechanical
Stimulation
Control
Camera
Control
Central  
OS 
User Interface
Decoder
Control
Figure 2.2: Block representation of the software architecture of the system.
2.3.4 Components Design
In this components design step, both the hardware and software architectural
designs are decomposed into detailed hardware and software components. The se-
lection of the components in this step is based on the functional and non-functional
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blocks in the architecture design. They can be chosen from the ready-made com-
ponents, or they need to be designed by the designer.
Hardware Components Design
A) Central Control Block. The central control block is composed of the
Raspberry Pi(RPi) 3 Model B Microcomputer. The RPi contains Raspbian OS
and it can be used as a computer. Besides that, it has several advantages as Quad-
core, 1GB RAM, HDMI Port and 40 GPIO pins [21].
The RPi communicates with the electrical stimulation block through the I2C inter-
face. While it controls the mechanical stimulation block through the GPIO interface
and through its camera port it controls the real-time monitoring block. The user
can control the system through the USB port and can setup the test parameters
through the monitor which is connected to the RPi through HDMI cable.
B) Electrical Stimulation Block. As it is mentioned earlier, the electrical
stimulation block generates the voltage signal necessary for the cell differentiation
and it should be configurable for the waveform amplitude and pulse width.
So, the Digital to Analog Converters (DAC) and digital potentiometers are deployed
to meet all these requirements. The sampling frequency can be set by controlling
the writing interval of the DAC. The amplitude of the waveforms can be controlled
though the value of the digital values of the DAC and the amplitude range can
be set through the digital potentiometers. The bipolar waveform can be generated
through two DACs with complementary voltage outputs. The MCP4275 DAC is
selected for the digital to analog conversion as it has a 12-bit resolution, can work
between 2.7V and 5.5V. It can also be controlled through the I2C interface and can
easily be controlled by external devices.
C) Mechanical Stimulation Block. The mechanical stimulation block gen-
erates the mechanical stimulation signals through the interaction between the poly-
mer materials of the 3D scaffold and a mechanical motor. The 3D scaffold hosts the
stem cells, while the motor generates the movements. Besides that, the rotational
encoder is attached to the motor so that it can generate electrical encoding outputs
for each rotational position of the motor.
There are usually 3 types of motors, such as DC motors, servo motors and stepper
motors. The DC motor is used for applications where the continuous rotation is re-
quired. While the servo motor can generate very high torch with accurate rotation
angle. The stepper motor is used in applications where a slow periodic movements
are needed. The mechanical stimulation signal is generated through the rotation
of the motor, so a highly precise motor control is necessary for the safety of the
stimulation of the cells. In this design, the NEMA 11 11HS12-0674S stepper motor
is chosen. It has the rotation accuracy of 1.8 degree, can generate high torch and
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can be controlled through its driving circuit which can be interfaced easily to ex-
ternal embedded systems. The Figure 2.3 shows the prototype of the mechanical
stimulation unit that is composed of a stepper motor, a rotational encoder, and a
3D scaffold.
Figure 2.3: The motor and scaffold connection [22]
D) Real-time Monitoring Block. Real-time monitoring of the stem cells can
be helpful for the observation of the stem cells. A properly designed monitoring
system can keep track of the cells under stimulation. For this, we have developed a
digital microscope using the RPi camera, standard 20X microscope objective and
custom holders. The RPi camera module is equipped with 8MP optical sensors and
can be connected to the RPi through the CSI interface. The Figure 2.4 shows the
RPi camera with its connection to the RPi: In order to integrate the RPi Camera
module with the microscope objective, we have removed the lens of the camera
module and placed the camera module directly on top of the microscope objective.
In this way, the amplified objects can be sensed directly by the camera module and
can be visualized inside RPi. Then we have designed specific holders for the camera
module and the microscope objective in order to fix them on the metallic holder.
Figure 2.5 shows the first prototype of the RPi camera based digital microscope.
The RPi contains the libraries for capturing videos and images and also for real-
time display. So, there is the possibility to monitor the stem cells under stimulation
in real-time thanks to the camera libraries inside the RPi.
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Figure 2.4: The Raspberry Pi camera [22]
Figure 2.5: The Raspberry Pi camera based microscope [22].
Software Components Design
According to the specification of the bioreactor system, the generated electrical
and mechanical signals should be configurable in terms of frequency, amplitude and
waveform type. So, in order to make the system configurable, a user configurable
software application is developed inside the Raspbian OS running inside the RPi.
The main task of the software application is to control the electrical stimulation
unit, mechanical stimulation unit and camera monitoring unit, to establish the
communication between these units and RPi, and also to carry out data analysis
and generate commands inside the RPi.
The software is developed in QtCreator 5.3 using the C++ programming language
and also the Qt libraries. The advantage of using the Qt software development
environment is that, once the application is ready, it can run on Windows, Linux
and MAC, so the application will be a cross-platform application supporting all
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types of main operating systems.
In this section, the detailed software components of the whole system is explained.
it is composed of electrical stimulation, mechanical stimulation, camera monitoring
and decoder control blocks. The overall software architecture is shown in Figure
2.6.
Figure 2.6: Software architecture of the bioreactor system [22].
A) GUI. It can be seen that the software application of the system is com-
posed of five different projects: Graphical User Interface(GUI) project, electrical
project, mechanical project, camera project and decoder project. The GUI project
is the core of the all projects and it controls the whole application. It contains a
user interface that configures the experimental parameters for the electrical and
mechanical stimulation and also controls the RPi camera. The communication be-
tween the GUI project and other projects are based on TCP/IP communication as
there are QTCP clients that correspond to the electrical stimulation, mechanical
stimulation, decoder control and camera monitoring inside the GUI. While in each
of the electrical project, mechanical project, decoder project and camera projects,
there are corresponding QTCP servers that communicate with the clients inside
the GUI through given IP and ports. The clients and servers in these projects run
on individual threads, so that the mechanical stimulation, electrical stimulation
and camera control tasks can be carried out independently. The Figure 2.7 shows
the graphical user interface used to control the whole bioreactor stimulation and
monitoring system.
B) Electrical Stimulation Block. As it is mentioned earlier, the GUI project
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Figure 2.7: Graphical User Interface of the bioreactor system [22].
contains the thread that controls the electrical stimulation and interacts with the
electrical project. This thread contains a TCP client that communicates with the
TCP server inside the electrical project.
After the test parameters for the electrical stimulation are set, the user clicks the
start button in the electrical stimulation panel. Then the electrical thread will cre-
ate a process and run the electrical project by forwarding the test parameters. After
the parameters are received, they will be extracted inside the electrical project and
the DAC samples will be generated from these parameters. Then TCP server inside
the electrical thread will be ready for the communication with the GUI project and
wait for the TCP client connection from the IP address and port parameters.
When the TCP/IP communication is established, electrical project will send back
the digitally created samples to the GUI project in order to confirm that the pa-
rameters are received by the electrical project. Then the GUI project will send
the start command and the electrical project will start sending the samples to the
DACs and generate the desired electrical signals. The Figure 2.8 shows the detailed
work flow of the electrical thread inside the GUI project and the Electrical project.
C) Mechanical Stimulation Block. This part explains the firmware related
to the mechanical stimulation. The mechanical thread created inside the GUI
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Figure 2.8: Work flow of the electrical stimulation process on the client and server
side [22].
project contains two clients, one for communicating with server inside the mechan-
ical project, one for the server inside the decoder project.
After the test parameters are set in the mechanical stimulation panel, the mechan-
ical thread creates two processes for the mechanical project and decoder project.
The mechanical project controls the rotation of the motor through the motor driver,
while the decoder project controls decodes the incoming electrical signals from the
optical encoder and sends the rotation position to the mechanical project as a feed-
back. In this way, the mechanical project can track in real-time the rotation of the
motor and can guarantee a safe operation of the motor. Figure 2.9 displays how
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the mechanical thread works inside the GUI project. The Figure 2.10 explains the
Figure 2.9: Work flow of the mechanical thread on the GUI project [22].
work flow on the mechanical project.
D) Decoder Block. Figure 2.11 explains the work flow of decoder block. The
project measures the rotation angle of the motor and then gives a feedback to the
mechanical project in order to guarantee a safe rotation range of the motor.
E) Real-time Monitoring block. The camera project controls the camera
and captures images, videos, displays the observation of the microscope objective
in real-time.
The different operations can be executed through the TCP/IP communication
between the camera thread inside the GUI project and the TCP server inside the
camera project. When the video recording is on, the elapsed time will also be
displayed on the panel. In Figure 2.12 is depicted the work flow of the camera
thread inside the GUI project, while Figure 2.13 shows the work flow of the camera
project.
2.3.5 System Integration
In this step, the hardware and software components are placed together and the
complete system is built. Figure 2.14 presents the first prototype of the bioreactor
system that is capable of generating electrical and mechanical signals, and can also
carry out real-time monitoring of the cells inside the 3D scaffold.
28
2.3 – Model Implementation
Figure 2.10: Work flow of the mechanical project [22].
2.3.6 System Refinement
As previously mentioned, during the design, the successive refinement approach
is adopted. After the design of the first prototype, the hardware and software func-
tional blocks are tested and the design techniques are validated. The improvements
in each functional block are described in this section.
Central Control Block
The main update in this block in the new version is the usage of more powerful
Raspberry Pi (RPi) 3, as it has higher performance with more robust internal
hardware resources.
Electrical Stimulation Block
In the first prototype of the system, the electrical stimulation hardware block
generates only a square wave voltage, while in the new version, besides the square
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Figure 2.11: Work flow of the decode project [22].
wave signal, the system is also able to generate Triangular, sinusoidal, Gaussian 1st
derivative and Gaussian 2nd derivative waveform. Besides that, it is possible to gen-
erate each waveform with desired frequency instead of a fixed one. The amplitude
can also be changed. While the electrical stimulation software block provides the
user with an updated interface with more options to set the stimulation waveform.
Mechanical Stimulation Block
In the first version of the system, the rotation of the motor is not stable and it
is addressed in the new version. The accuracy of the rotation is improved from the
mechanical software block. More stimulation signal types are added, such as the
triangular and square with tunable frequencies and rotational angles. The shaft in
the first version is replaced with a 3D printed wheel in order to have a traceable
stretching amplitude on the connected polymer material inside the scaffold.
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Figure 2.12: Flow chart of the camera thread inside the GUI project [22].
Real-time Monitoring Block
In the new version, the monitoring of the camera is based on the GPU of the
RPi and it supports much higher frame rate and there is the possibility to capture
images and videos. The other change is in the microscope holder and it is very
light with better usability.
2.4 Validation of the System
In the previous sections, the different units of the bioreactor system were ex-
plained. After the design of the system, the next step is the validation of the system
to check if it could carry out the tasks specified during the documentation of the
overall system and function correctly, according to the configuration set through
the user interface.
2.4.1 Electrical Signal Generation
This section contains the validation for the electrical signal generation unit.
As indicated before, the electrical stimulation unit should be able to generate dif-
ferent shapes of waveforms, such as Sinusoidal, Triangular, Square, Gaussian 1st
derivative, Gaussian 2nd derivative and ECG (an artificial reproduction of an Elec-
troCardoGraphic signal). Besides that the system should be able to generate each
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Figure 2.13: Flow chart of the camera control process on the server side [22].
Figure 2.14: First Prototype Electrical-Mechanical Stimulation and Monitoring
System [22].
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type of the waveform with the frequency and amplitude indicated in the user in-
terface.
2.4.2 Mechanical Signal Generation
In this section, the validation is carried on the mechanical signal generation
unit. According to the requirements on the mechanical stimulation, the mechanical
stimulation unit should be able to generate mechanical movements that vary in the
sinusoidal, triangular and square forms.
In order to carry out the validation, the mechanical waveform parameters are set
and the mechanical signal generation starts. In order to check if the mechanical
movement corresponds to the assigned frequency of the setup, the rotational en-
coder output is measured. As the movement is periodic, the output of the encoder
will also be periodic and its output signal can be displayed in the oscilloscope.
Then we can measure the period of the waveform and compare it with the preset
value. Figure 2.15 shows the output channels of the encoder and it can be seen
that the movement of the motor is periodic. By measuring the repetition period
of the waveform we can measure the frequency of the rotational movement of the
motor.
Besides the frequency, the next parameter is the amplitude of the mechanical wave,
Figure 2.15: Encoder output at the mechanical stimulation [22].
or let us say the maximum rotation angle of the waveform. This can be measured
through the ImageMeter Pro application. Here in the Figure 2.16 below is the angle
measurement from ImageMeter Pro and it displays the maximum rotation angle of
30.2 degrees, which is quite close to the preset amplitude of 30 degrees.
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Figure 2.16: Measurement of rotation angle from the ImageMeter Pro application
[22].
2.4.3 Real-time Monitoring
This section includes validation on the monitoring unit. The Figure 2.17 shows
the setup of the test and there is the nano gap circuit placed under the custom
designed microscope. The objective is the standard 20X one, which amplifies the
nano gap circuit by 20 times. The focus of the microscope can be adjusted manually
in order to have best resolution of the monitoring image.
Figure 2.17: Setup for observing nanogap circuit using the monitoring system [22].
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2.5 Experimental Results
This section presents some results on the system regarding the differentiation of
Mesenchymal stem cells (MSCs) into tendon cells using mechanical and biochemi-
cal stimulation. Figure 2.18 shows the bioreactor model [23].
In this figure: A) demonstrates the schematics of the bioreactor function and pur-
pose. After mounting the samples into the bioreactor system, stimulation is carried
on under tensile cycle load in order to perform dynamic culture of the cell and
improve cell proliferation alignment. B) shows the Raspberry Pi based electronic
circuit that drives the stepper motor and stimulates the scaffolds through a wire.
C) is the chamber model designed in SolidWorks. D) presents a PMMA model
which is designed to minimize the working volume and maintain the sterility. In
E), the samples were loaded in the chamber and stimulated mechanically for 7 days
(4 hours/day). F) shows the mounting of the scaffolds into the bioreactor system,
incubation and culturing under dynamic condition [23]. In Figure 2.19, the de-
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Figure 2.18: Bioreactor Model [23].
tailed steps involved in the cell differentiation are shown. The detailed explanation
of each step can be found in [23]. The Figure 2.20 shows the stimulation of cells
under Static Condition (SC) and Dynamic Condition (DC) in 7 days. In static
condition, no mechanical stimulation is applied.
Figure 2.20.A) shows the fluorescence images of the cell cytoskeletons after 7 days
of culture and we can see the cell alignment in the direction of the stretching for
the scaffolds stimulated mechanically, while cells cultured under static conditions
show random orientation.
Figure 2.20.B) shows the alignment of cells quantitatively and reports upto 40%
cell alignment in the direction of the strain under mechanical and biochemical stim-
ulation.
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Figure 2.19: Experimental steps [23].
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Figure 2.20: Results on the mechanical and biochemical stimulation of MSCs [23].
2.6 Discussion an Conclusion
In this project, a novel type of smart, flexible and easy-to-use bioreactor system
is designed and validated. Starting from the requirements and specification of
the system, choosing the architecture, the components, designing the hardware,
validating the system and carrying out experiments, we have strictly followed the
successive refinement model design procedure.
The system is smart, because it can carry out operations without the involvement
of the user, such as the controlling of the motor, automatic tracking of the motor
rotation, estimating the safety status of the motor and carrying out corrections.
In this version, machine learning algorithms have not yet been implemented, but
there are plenty of libraries available inside Raspberry Pi 3 and they will be studied
and integrated into the system in order to make it more smart.
36
2.6 – Discussion and Conclusion
The system has been successfully tested on the generation of tendon cells in the
Khademhosseini Lab at MIT premises in Boston, and we were able to differentiate
the stem cells into the tendon cells by providing proper physiological environment
and a mechanical stimulation from our system. The relevant results were recently
accepted as publication in the ACS Journal on Biomaterials Science & Engineering.
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Chapter 3
Wearable Wireless Surface EMG
System Design for Muscle
Synergies
3.1 Introduction
3.1.1 Muscular System
Brain is an organ which is center of the nervous system in all living animals and
human. Its function is to control other organs of the body. A neural accident such
as a stroke or traumatic brain injury or spinal cord injury can cause changes in mo-
tor functions of the patient which include physical, social and mental disabilities.
This maybe caused by a compromised nervous system that results in damaged mo-
tor nerves and it can be also due to the interruption of the communication between
the central neural system and different parts of the body [24].
In human body, the muscular system cooperates with other organ systems such as
skeletal system and neural system in order to carry out movements of the body,
posture and stability control, blood circulation, heat production and help in di-
gestion. The movement is generated from the muscular system when an electrical
stimulus is received from central nervous system. This stimulus is called action
potential and it creates voluntary or involuntary movements of the muscles.
The muscular system is composed of three types of muscles:
• Skeletal Muscle: The muscle is attached to the bone through tendons and
it carries out movements such as locomotion, posture, facial expressions and
other types of voluntary movements of the body [25].
• Cardiac Muscle: This muscle exists in the walls of the heart and this muscle
works in autonomous and rhythmical way [26].
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• Smooth Muscle: This muscle exists in blood vessels, internal organs and other
parts that carry out involuntary movement [26].
When the voluntary movements of the human body are carried out through the
contraction and relaxation of the skeletal muscle, electrical signals are generated.
These signals are controlled from the central nerves system and are dependent on
the type of the skeletal muscle [27]. So, measuring these signals can help clinicians
understand the disorders of the motor control in the patients that suffered neural
accidents. The technique used for the measurement of these signals is called Elec-
tromyography (EMG).
3.1.2 Surface Electromyography (sEMG)
The EMG technique can be divided into two types: Surface EMG and the intra-
muscular EMG. The surface EMG carries out the assessment of the muscle function
by recording from the surface on the skin the muscle activity. The intramuscular
EMG records the electrical signals by inserting the electrodes into the target skele-
tal muscles.
Once the EMG data is available, the next step is to calculate muscle synergy data
using Non-Negative Matrix Factorization (NNMF) method. In this way, the con-
tribution of muscles in each synergy can be obtained and therefore, it is possible
to evaluate the activity of each muscle from the calculated synergy data [28].
In this research, the surface EMG is studied as it has following advantages:
• It can give information on the duration, on the moment, on the activation
entity of a muscle during movements;
• It is possible to provide indications on the overall activity of a muscle group
or an individual muscle;
• It can demonstrate the maximum degree of relaxation or contraction of mus-
cles or muscle groups of the patient, which is also called the Bio-feedback;
• It can provide analysis on the muscle in an non-invasive approach;
• It can be used for controlling other devices;
• It is possible do carry out long-lasting and dynamic tests with this technique;
• It is easy to carry out and is painless.
So, with all these advantages, it has become a very popular technique in the clinical
and rehabilitation applications [29].
Currently, there are ways of setups in recording the sEMG signals, depending on the
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materials, detection configurations and dimensions. Materials that are mostly used
for fabricating sEMG electrodes are silver chloride(AgCI), gold(Au) or silver(Ag)
or mix of silver and silver chloride(Ag/AgCI). The main reason for using these ma-
terials in the fabrication is that the polarization of the electrodes can be avoided,
the surface potential sensitivity to the movement artifacts of the electrode can be
reduced and the electrode-skin interface stability can be increased by interposing a
conductive gel layer [30].
Besides the differences in the materials, the sEMG recording can be different also
based on the montage of the electrodes. There are commonly two types of record-
ing: a) monopolar and b) bipolar. The Figure 3.1 shows the two different types of
electrode configuration: It can be seen from the Figure 3.1 that, in the monopolar
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Figure 3.1: Electrode montage types and the detected action potentials in each
configuration [30]
configuration there are two electrodes: a reference electrode and a single surface
electrode. In the bipolar configuration, there are three electrodes: a reference elec-
trode and two surface electrodes.
The monopolar configuration has large sampling volumes and is very susceptible
to the disturbances. It also keeps all the information in the captured signals with
no spatial filtering. The bipolar configuration has a reduced sampling volume and
is less susceptible to external disturbances. Therefore it can provide a more clean
and stable signal compared to the monopolar configuration [30].
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3.1.3 Commercial EMG Devices
There are many existing commercial EMG devices for recording surface EMG
signals. Some popular ones are FREEEMG, PicoEMG, DataLITE sEMG.
A) FREEEMG B) PicoEMG C) DataLITE sEMG
Figure 3.2: Commercial EMG Devices
• FREEEMG: This device is produced by BTS Engineering and it supports
upto 20 probes for simultaneous signal recording. It has a battery life of 6
hours for a continuous acquisition. It has a dimension of 41.5×24.8×14mm.
However, it does not support a uSD Card storing.
• PicoEMG: This device is produced by Cometa and it is based on two monopo-
lar electrode configuration. It can support synchronous acquisition of upto
32 devices and it can support upto 12-hour continuous signal acquisition with
wireless transmission and 8-hour data logging with memory on board.
• DataLITE sEMG: The DataLITE sEMG is produced by Biometrics ltd. It
has adimention of 42 × 24 × 14mm. It can support upto 8-hour continuous
signal acquisition.
3.1.4 Research Objective
As it is reported in section 3.1.3, all these available sEMG devices cannot last
beyond 12 hours for a long term monitoring. Therefore, it is necessary to develop
a low-power sEMG system that supports multiple channel acquisition with a long
lasting battery life as possible.
3.1.5 Project Analysis
In this project, the aim is to design a low-power surface EMG that could last as
long as possible for a continuous measurement on a single charging of a battery. Be-
sides that, the system should be wearable, synchronous among probes and wireless.
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So, the challenges are on the power consumption, dimension, wireless communica-
tion, timing and of course the cost. All of these constraints put limits on type of
the electronic system, selection of components, design approach and techniques.
From the goal of the system, what is needed is a stand-alone low-power embedded
system that can work continuously for the expected amount of time, such as several
days. Therefore, for the design of the system, it is necessary to follow the embed-
ded system design methodologies thanks to the advantages of such approached
described in Chapter 1.
Regarding the designing of the system, the idea is to select an architecture, define
the technology, design the first prototype and then improve the system step by step.
So, the successive refinement model is the right choice for designing and validating
the design concepts and techniques then refining it in the next versions of the design.
3.2 Model Implementation
The section is dedicated to how the steps are realized in the successive refinement
model. In this model, the first step is to describe the requirements of the system,
then list all the possible specifications followed by the architecture. Then the
implementation of hardware and software components is described with system
integration at the end. After the first prototype is ready, the next cycle starts with
the improvements in each step and so on.
3.2.1 Requirements
The requirements of the system include both the functional descriptions and
non-functional descriptions. The functional requirements can be summarized in
the following list:
• Measurement of surface EMG signals;
• Simultaneous recording from up to 16 measuring probes;
• Long-term monitoring;
• Wearable system;
• 1KHz signal sampling frequency;
• Local storage of data;
• Clean and stable EMG signal
• Wireless control of measurement probes.
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Non-functional requirements can be summarized in the following list:
• Affordable cost;
• Data collection and processing capability;
• Reliable wireless communication between the controlling and measurement
nodes;
• Battery powered;
• Acceptable design time.
3.2.2 Specification
After the description of the requirements, the next step is to list all the speci-
fications of the system. The specifications bridge the requirements of the user and
the implementations of the designer. The specifications that can be extracted from
the requirements can be summarized in the following list:
• The recorded signals are the electrical signals measured from skeletal muscle
contraction;
• The system should be able to filter the recorded signals in order to obtain the
signals of interest;
• All measurement probes should record signals synchronously;
• There should be functional blocks that keep a stable working environment of
the system under a battery;
• The dimension of the measurements probes of the system should not be very
big;
• The system should have a signal sampling unit that can sample at a frequency
of 1KHz;
• The system should have local storage units that can store the recorded signals;
• The recording signals should be clean and insensitive to movement artifacts;
• The central control probe should be able to communicate wirelessly with all
measurement probes without packet loss;
• The system should not cost too much in terms of component selection and
design;
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• The system should have internal data processing units that can process and
store or transmit processed data;
• The system should be able to work under low voltage supplies;
• A proper design process should be followed in the design.
3.2.3 Architecture
After the system specifications are listed, the system should be designed at ar-
chitectural level. Since the embedded system contains hardware and software, the
architecture design should consider both cases.
Hardware Architecture
A possible hardware architecture that could meet the specifications can be fol-
lowing as shown in Figure 3.3.
Recording
Electrode
Recording
Electrode
Reference
Electrode
Overvoltage
Protection
Overvoltage
Protection
Voltage
Follower
Voltage
Follower
Differential
High Pass
Filter (30 Hz)
INA
(Gain 922)
Low Pass
Filter (400 Hz)
Low Pass
Filter (10 Hz)
Central
Control
Local Data
Storage
Power
Management
Figure 3.3: Hardware architecture of the EMG probe
A) Central Control. The Central Control Unit can sample the signals with
1KHz frequency. It can process the signals coming from from the EMG Analog
Front End unit. It can communicate with central control probe and exchange data
packets. It can also store the processed data into local storage unit.
B) EMG Analog Front End (AFE). The EMG AFE unit has the func-
tionality of removing spikes from recorded signals, buffering the recorded signals,
providing bipolar electrode configuration, filtering out the noise and movement ar-
tifacts from the captured signals and finally adjusting the processed signals into
measurable signal ranges.
C) Local Storage. The Local Storage unit contains µSD Card data storing
block and it is used for local data logging.
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D) Power Management. The power management unit is responsible for
conditioning the battery voltage and supplying the whole hardware with a stable
operating voltage.
Software Architecture
Besides the hardware architecture, there is also the need for the software archi-
tecture considering the specifications of the system. The software architecture can
be following as shown in Figure 3.4.
Wireless
Communication
Radio
Control
Central
Control
Timer
Data
Processing
Signal
Sampling
Local Data
Storing
PPI
Figure 3.4: Software architecture of the EMG probe
3.2.4 Components Design
The next step is to implement the detailed design according to the functional
blocks inside the hardware and software architectures. During this step, hardware
components that meet the functional requirements of the hardware architecture are
selected if they are ready to use, otherwise they are designed.
Hardware Components Design
A) Central Control Unit. From the specifications of the system, there is
a strict timing requirement on the synchronous acquisition of signals from each
measurement node. The communication is wireless, which means there should
be a radio transceiver hardware. Besides that, there are many types of wireless
communications, such as WiFi, Bluetooth Low Energy(BLE), ANT, Lora, Zigbee,
etc. So, it can be very helpful if there is a hardware platform that could support
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multiple communication standards so that a proper, reliable communication type
with acceptable synchronization accuracy can be selected through software when
the system is complete. The low power consumption requirement should also be
respected. So, the nRF52832 micro-controller is selected as the central control unit
and it has following advantages compared to other stand alone embedded systems:
• Multiple wireless communication standards
• In-built high performance Microprocessor
• Rich in hardware resources and communication interfaces
• Small dimension
• Exceptionally low power consumption
It has many types of hardware interfaces, such as SPI, I2C, I2S, UART, etc. It also
has plenty of well-written software libraries with many examples. Besides that, it
contains 12-bit Analog to Digital Controller with adjustable sampling frequency.
So, the nRF52832 can be a good choice for the design of the initial prototype of
the system.
B) EMG Analog Front End. The detailed design of the AFE is based on
the hardware architecture shown in Figure 3.3. The overvoltage protection block
is added in order to avoid possible voltage overshoots so that the recorded input
voltage will be limited in a safe range. The detailed circuit design is shown in
Figure 3.5.
In this design, Zener diodes of the model ESD5Z3.3 are selected as they have
In1
In2
Ref
TPD2E001
10K
10K
1K
1K
ESD5Z3.3
ESD5Z3.3
CMAD6001 CMAD6001
BLM15
BLM15 T1
T2
Figure 3.5: Overvoltage protection circuit
small dimension, very low leakage current and fast response time. Besides that,
BLM15AX102SN1 ferrite bead is selected for additional protection. The TPD2E001
is selected as it is composed of double channel transient protection diode array.
The voltage follower is composed of an OPA2347 operational amplifier as this chip
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has a very low quiescent current (0.034 mA maximum). Then comes the high pass
filter composed of passive components and the schematics is shown in Figure 3.6.
The instrumentation amplifier is based on an INA321 that has an adjustable gain
10M
10M
10M
10M
470pF
470pF
T1
T2
H1
H2
Figure 3.6: Differential High Pass Filter with 30 Hz cut-off frequency [31]
between 5 to 1000 V/V. The gain can be set through the connection of two re-
sistors R10 and R11 to the chip, shown in Figure 3.7. The formula for the gain
is: G = 5 + 5(R11/R10). However, with the commercially available resistors, it
is possible to reach a gain of 922 instead of 1000. In order to filter out the low-
VDD
100nF
1.2k 220k
H1
H2
INA_OUTINA_RIF
INA321
Figure 3.7: INA321 configuration circuit [32]
frequency voltages coming from INA reference voltage, a low pass filter with cut-off
frequency 10.43 Hz is designed and connected to the reference voltage input pin 5
of the INA. The low pass filter is based on a multiple-feedback architecture and the
actual design of the filter is shown in Figure 3.8.
Besides the low-pass filter for the INA321 feedback, there is a need to implement
another low pass filter for processing the measurement signals. This filter is based
on Sallen-Key architecture and its implementation is shown in Figure 3.9.
Then the output of the filter is connected to the ADC input of the nRF52832
Micro-controller. In both cases, the OPA333 operational amplifier is selected for
the design due to its minimum Common Mode Rejection Ratio of 106 dB. It has a
typical quiescent current of 17 uA, a wide supply voltage range between 2.7 V and
7 V. It also has a low input voltage noise of 0.3µVpp in the frequency range from 1
mHz to 1 Hz.
C) Local Storage. The Local storage unit is responsible for storing the data
locally. So, there is a need for a memory chip that can store the data and provide
an easy to read access. Therefore, a µSD Card slot is selected in the design as
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Figure 3.8: Multiple-feedback Low Pass Filter Circuit
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AFE_OUT
Figure 3.9: Sallen-Key based Low Pass Filter Circuit
the normal PCs contain a µSD Card reader so that the measurement data can be
fetched easily. In this research, the 16 GB Apacer Micro SDHC Class 4 Memory
Card is used for storing the measurement results or processed data.
D) Power Management. The power management unit supplies the whole
system with a stable operating voltage. Since the embedded system is powered by
a coin battery, the output voltage of the coin battery drops as time passes by. So,
it is necessary to design a voltage supply block that can produce a stable output
voltage regardless of the drop of the input voltage. This means that it is necessary
to use a step-up boost voltage regulator. There is also a need to prevent a reverse
connection and a diode would be necessary for this purpose. The typical operating
voltage of the µSD Card is 3.3 V, so it might not work properly if the voltage level is
lower than this due to the voltage drop in the circuit. Therefore, an output voltage
of 3.6 V will guarantee the normal operation of µSD Card. The actual design of
the voltage regulator block is shown in Figure 3.10.
Software Components Design
A) Central Control. This software unit is responsible for initializing the
whole software and hardware by calling corresponding initialization functions. It
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VBAT
150uF 10uF
TPS610995
10uF
2.2uH
VDDSD0805
Figure 3.10: 3.6 V boost step-up voltage regulator
also handles interrupts and calls specific operations based on the interrupt flags.
B) Peripheral Programmable Interconnect (PPI). One of the amazing
features of the nRF52832 is the Peripheral Programmable Interconnect system. It
can enable interconnection between peripherals with each other using tasks and
events without the need of CPU. It can also allow synchronization between periph-
erals to meet timing constraints of the applications [33].
  		

 ! "!#$%##%$
&		
’(
))*	*)+,
*))-)./)..0123&,)))+4
,
),5	))6).	).012/+
		
/,
.0.*)3
789:;<89=>?@
789:;<89=>?A
789:;<89=>?@
789:;<89=>?A
BC8DE?@
BC8DE?A
BC8DE?@
BC8DE?A
BC8DE?F
G=HI?@
G=HI?A
G=HI?F
G=HI?@
JKLMNOBB7
JKL@NOBB7
JKLDNOBB7
JKLMNOGB7
JKBP
@QRKS
TUVWLMNOGB7
M
@
D
JKXLMN
M
@
D
JKXLYN
M
@
D
OO
Z![\]%^_!
&)+)	)‘..0*+		
)‘)0)
,/.’aa(.)-.)’&a(06..,3&)06.)

./.*+
.‘.)
.‘...*))	,+).+
)3
bcd]e#f![#_f!g_%"##h
ijklmjno pqmjjor stuvowxyzxnqmjjork stuvowxyzx{wyt|k
}}~  
}}~  

&/.)	)	*	+)-))*0/
*3)-)./*3&
)	).0.))‘aa.,&a)3)-).&a
*)..))0)-))).,)-3	+‘/).
aa*)..))0/))).,/3
‘)))+4.4-‘/.+/0
)*..	)3))*‘/))+*)4-,
.+.

+-.‘,)+*)/),
.+.
+*4-.3
Figure 3.11: Block diagram of PPI
C) Timer. The timer unit contains the setup and relevant operations carried
out by the timers. Two high frequency timers with 16 MHz and one Real-Time
Counter (RTC) with 32.768 KHz frequency are used. One of the high frequency
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timer(let us call it radio timer) controls the radio block inside the nRF52832 micro-
controller for the wireless communication, while the other one controls the synchro-
nization of the node(let us call it synchronization timer). The RTC timer is also
used for controlling the radio block.
In Figure 3.12, graph representation of the whole system shown. It includes the
central node (also called master node) and measurement nodes (also called slave
node). The master node controls all the other slave nodes, so they communicate
Master Node
Slave Node 1 Slave Node 2 Slave Node 16
Custom Radio
Protocol
Figure 3.12: Graph representation of the overall system
via custom radio protocol. Since the recording of EMG signals on each slave node
should be synchronous, the idea is to synchronize the synchronization timer in the
slave node with the one in master node. Once the timers are synchronized on both
master and slave node sides, then the recording of signals can be synchronized as
the recording is controlled by the synchronization timer. The synchronization pro-
cess is shown in Figure 3.13. In the first step, the master node is in transmission
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Figure 3.13: Synchronization process of the whole system
mode, while all the slave nodes are in reception mode. The master sends its clock
information via the 2.4 GHz Enhanced Shock Burse (ESB) wireless radio protocol
then it switches to the reception state and waits for the feedback from each slave
node in a time duration of 30 ms. Once the slaves have received the packet from the
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master, they adjust their synchronous timer with the one of the master and they
in turn change their status from reception to transmission state. Then they send
their feedback to the master node. After the master node receives the feedback of
all slave nodes, then it can send the start measurement command and the slave
nodes can start recording signals.
D) Signal Sampling. The sampling of the signals is carried out through the
internal 12-bit Analog to Digital Converter (ADC) of the nRF52832 and the ADC
is controlled through the synchronization timer in order to guarantee a precise 1
KHz synchronous sampling.
E) Local Data Storing. The data storing is based on the FatFs library of the
nRF52832 and corresponding data storing operations are called when the central
control block wants to write the measurement data into the local µSD Card. This
unit also contains an FIFO with 7 internal buffer blocks in order to guarantee an
independent signal capturing and data storage. On one side, measured or processed
data enters from the top; on the other side, the data inside the FIFO is shifted to
the local µSD Card. This can optimize the memory utility in the micro-controller.
The block diagram of the FIFO is shown in Figure 3.14.
FIFO IN
FIFO OUT
Figure 3.14: Block diagram of FIFO
F) Wireless Communication. The master node and slave nodes communi-
cate with each other using a custom radio protocol called Enhanced Shock Burst
Protocol. This protocol provides a reliable and configurable wireless communica-
tion. The data rate, maximum packet size, communication frequency, transmis-
sion and receiving power, device address and other relevant parameters can be set
through this library.
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3.2.5 System Integration
The final step is the integration of the hardware and software components. After
the software library is downloaded into the nRF52832 micro-controller, the next
step is to debug and test each individual hardware and software block. After the
individual tests, final tests on the complete system are carried out by synchronizing
the overall system, starting the measurements on the slave nodes, storing the data
locally and then stopping the measurements.
3.2.6 System Refinement
After the test and debugging of the first version, it is necessary to address
possible issues in the new version of the system. The previously described design
methodology steps are improved in order to design more refined system. So far,
three prototypes are designed and the differences between these versions can be
seen from Figure 3.15.
So, step by step the final system is optimized in each cycle of the successive re-
 1st Version 2nd Version 3rd Version 
System 
Image 
   
CPU nRF52832 nRF52832 nRF52840 
Area 57x37x10mm 29x27x11mm 57x32x11mm 
Hardware 
improvement 
Mainly designed for 
debug and test, may 
include additional 
components 
Step-up boost regulator is 
implemented, PCB stack 
architecture is applied. 
Area is optimized. 
Additional ATC 
hardware 
feature is added. 
Software 
improvement 
Basic custom radio 
communication 
protocol is 
implemented. High 
synchronization 
accuracy is achieved. 
More stable ESB custom 
radio protocol is included. 
Serial port library is 
added. External GUI is 
designed to control 
master node. Software 
Envelope, ATC libraries 
are implemented. 
Still under test. 
 
Figure 3.15: Brief comparison of the 3 prototypes of the system
finement model and a more robust, more stable system is designed. More hardware
and software functionalities are introduced in each cycle. For example, from the
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first version to the second version, besides the improvements in the hardware, sev-
eral additional software libraries are implemented for the different working modes
of the slave nodes and also for the serial port communication. A Graphical User
Interface (GUI) is designed in order to control the master node.
3.3 Experimental Results
In this section, the test results are presented in order to validate that the sys-
tem meets the requirements and specifications. The tests are done on the synchro-
nization, wireless data transmission, signal acquisition and also on graphical user
interface.
3.3.1 Synchronization
During the synchronization process, the master node sends its clock information
periodically to each slave node and thee slave nodes adjust their internal synchro-
nization timer. The synchronization accuracy depends on how often the master
node sends its clock. With a 1 second synchronization interval, the clock difference
in the synchronization timer of two slave nodes is obtained from oscilloscope and the
accuracy is 625 nanoseconds. In order to see if there is a drift in the synchroniza-
tion accuracy, the master board and two slave boards are left in the synchronization
process and after 16-hour continuous test, the accuracy is still kept at 625 nanosec-
onds. In Figure 3.13, a screen shot is captured from the synchronization process:
Figure 3.16: Synchronization of two slave nodes
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3.3.2 Signal Acquisition
As it is shown in Figure 3.15, in the second version of the system, software
libraries for different working modes of the slave nodes are implemented. Basically,
there are three working modes as shown in Figure 3.17: Raw Data mode, Envelope
mode and Average Threshold Computing (ATC) mode.
Figure 3.17: Different working modes of slave nodes
A) Raw Data
In this mode, the slave nodes do not carry out any post-processing on the ADC
output data and store them on the µSD Card. The figure 3.18 shows the acquired
raw data from the Biceps during the measurement:
B) Envelope
In this mode, the output data of ADC first passes the 2nd-order Butterworth
high pass filter in order to remove the DC components of the signal. Then the
absolute value is calculated. After that, it passes through a 4th-order Chebyshev
low pass filter in order to get the final envelope. In Figure 3.19, the intermediate
data corresponds to the data before passing through the Chebyshev low pass filter.
After the envelope is extracted from the original data, then by using Non-negative
Matrix Factorization approach, it is possible to extract the muscle synergies.
C) ATC
In this mode, every 130 ms the output data array from ADC is processed in
the Threshold Comparing algorithm and number of events where the signal level
crosses the pre-defined threshold is counted and then is stored locally. The Figure
3.20 shows the obtained ATC counting values from the ADC output data. After
the ATC data are obtained, the ATC envelope will be calculated and then using
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Figure 3.18: Raw data from the sEMG measurement
again Non-negative Matrix Factorization algorithms, the muscle synergies can be
extracted.
3.3.3 Wireless Data Transmission
Besides storing the data into the local µSD Card, the slave nodes can also send
the measurement results wirelessly to the master node. In raw data mode, due to
the fast sampling rate and huge amount of raw data produced on the slave node
slide, the master node can receive measurement data simultaneously from max-
imum 2 slave nodes and then transmits the data to the PC through serial port
communication. In envelope or ATC mode, the master node can receive measure-
ment results from all the 16 slave nodes since there is much less amount of data to
be sent from slave node side in every second.
3.3.4 Graphical User Interface (GUI)
In order to control the master node from PC, a graphical user interface is de-
veloped and is shown in Figure 3.21.
The user interface contains a serial port library which enables a serial port com-
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Figure 3.19: Envelope data from the sEMG measurement
munication between the PC and the master node. Each measurement types and
working modes are tests are tested and command/packet exchange between the PC
and the master node is successful.
3.4 Discussion and Conclusion
In this project, several versions of a wireless wearable sEMG system were de-
signed following the successive refinement methodology, and the final system is
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Figure 3.20: ATC data from the sEMG measurement
continuously optimized and refined. In the second version of the system, the fol-
lowing results are achieved with a 10-second synchronization period:
• Synchronization with <10 µs resolution;
• Synchronization period is adjustable;
• Clock drift <10 µs over 16 hours;
• Wireless transmission and local data storing
• Battery life can last up to 61.6 hours in ATC mode <12 hours (Cometa).
Additional tests are done on the current consumption in different working modes:
58
3.4 – Discussion and Conclusion
Figure 3.21: Graphical User Interface for controlling master node
Table 3.1: Current consumption test on different working modes
Operating conditions: Battery Capacity = 450 mAh
Sync Period = 10 seconds
Sync Accuracy = 10 us
Supply Voltage = 3.6 V
Test Type Current Consumption (mA) Battery Life (h)
Raw Data 14.0 32.1
Envelope 7.9 57.0
ATC 7.3 61.6
From the test results reported in Table 3.1 it can be seen that the designed
sEMG system it is the very first wireless wearable sEMG system that can work
in the three different modes mentioned earlier. It is also the most power efficient
system compared to devices available in the market. Its wireless data transmission
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and local data storage capabilities can allow the system to be used for both real-
time and long-term muscle movement tests, inside or outside hospitals.
The designed system is smart as it can carry out operations in a smart way: au-
tomatic synchronization of clock signals, peripheral to peripheral control without
CPU involvement, automatic data processing, filtering and storing, interrupt based
smart power management.
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Chapter 4
Electrochemical Sensing Platform
for Continuous Monitoring of
Anesthesia Delivery
4.1 Introduction
Recent studies show that the effect of a drug is strongly patient dependent, as it
changes with age, gender, metabolism, living environment and health status of the
patient [34]. So, the correct delivery and therapy of the drug can be very challenging
due to these factors. Personalized Medicines (PM) try to address these problems
by providing patient dependent solutions in order to deliver the right drugs and
limit the side effects of the drugs [35]. This is extremely important for the case of
Anesthesia, as it is a very powerful and fast acting drug that could endanger the
life of the patient if not carefully monitored [36]. So, there are anesthesiologists
that are responsible for the administration order, dose balance and delivery time.
However, there are cases when the wrong dose is delivered or a wrong drug is given
to the patient as shown in the Figure 4.1.
4.2 Drug Monitoring with Electrochemical Sen-
sors
Due to the potential risks with the drug delivery stated in the previous section,
the monitoring and measurement of the drug in patient needs to be very precise
and Therapeutic Drug Monitoring(TDM) can be the key to do this [37]. The elec-
trochemical sensors are ideal candidates for the measurement of drugs as they are
very precise, low cost and very sensitive [38].
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Figure 4.1: Drug administration errors
4.2.1 Electrochemical Sensing Techniques
Electrochemistry is the branch of chemistry which focuses on the interrelation
between the electrical effects and chemical effects. It studies the chemical changes
induced by the passing of electrical currents or electrons or vice-versa, where there
is the change in current due to the chemical effects [39]. These electrical or chemical
effects usually take place in the electrochemical cells, which consists of electronic
conductors(electrodes) and and ionic conductors(electrolytes). The most common
configurations of the electrochemical cells are two-terminal configuration and three-
terminal configuration shown in Figure 4.2. In the two electrode configuration, the
Figure 4.2: Typical Electrochemical Cell configuration [39]
electrochemical cell is composed of the Working Electrode(WE) where the electron
exchange with the solution takes place, and the Reference Electrode(RE) which
provides a stable reference potential for the measurement of the potential of other
electrodes. This configuration is mostly used in applications where the voltage drop
between the WE and RE is relatively small. In the three electrode configuration,
there is an additional electrode, called Counter Electrode(CE), that enables the
measurement of the faradaic current passing through the WE when a voltage is
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applied between WE and RE [40]. The three electrode configuration is mostly used
in applications where the voltage drop between WE and RE is relatively big. In
the two electrode configuration, the RE works as supplier of the electrons and also
as a reference potential, so it is very difficult to keep it stable. So, in this project,
the three electrode configuration is adopted.
A typical electrochemical measurement is done by applying an excitation potential
between the WE and RE, then measuring the generated current.
In order to monitor the concentration of the Anesthesia compound, the follow-
Figure 4.3: Typical Electrochemical experiment
ing electrochemical techniques are used in this project: ChronoAmperometry(CA),
Cyclic Voltammetry(CV) and Differential Pulse Voltammetry(DPV).
ChronoAmperometry(CA)
In CA, a fixed potential is applied between WE and RE. Then the current
change with respect to the variation of concentration of the drug is observed. The
relationship between the concentration and current is expressed by the Cottrell
equation:
i(0, t) = nFA
√
DC(0, t)√
π × t (4.1)
While the change of the current with respect to the metabolic concentration is given
by:
∆i = nFA
√
D√
π ×∆t0
∆C (4.2)
The typical curves for these equations are shown in Figure 4.4.
Figure 4.4: ChronoAmperometry(CA) [40]
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Cyclic Voltammetry(CV)
In CV, a voltage sweep with a fixed voltage step is applied between the WE
and RE, then the current response for each step is measured. A typical curve of
the voltage scan and the current response is shown in Figure 4.5.
Figure 4.5: Cyclic Voltammetry(CV) [39]
Differential Pulse Voltammetry(DPV)
The DPV is a technique where a voltage pulse with an increasing step is applied
and the current responses before and after applying the pulse are measured. A typ-
ical curve of the DPV voltage sweep and the expected voltage-current relationship
is shown in Figure 4.6
Figure 4.6: Differential Pulse Voltammetry(DPV)
4.2.2 Sensor Calibration
In the electrochemical applications, the sensors are designed and developed ac-
cording to the requirements of the applications. The main common features of
sensors are:
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· Selectivity: the sensor is specific towards a desired analyte;
· Sensitivity: the ability of the sensor to detect the variations of analyte concen-
tration;
· LOD: the minimum concentration of the analyte that a sensor could detect;
· Dynamic Linear Range: the ability of the sensor to follow the rapid changes in
the analyte concentration.
So, before a sensor is used, it is needed to be calibrated. The calibration line of
the sensor shows the relationship between the variation of the concentration of the
analyte and the generated current.
4.2.3 Research Objective
The objective of this research project is to design an electrochemical biosensing
platform that could carry out real-time monitoring and delivery of anesthesia com-
pounds, such as Paracetamol (APAP), Propofol and Midazolam. Electrochemical
techniques such as CA, CV and DPV should be supported by such platform. For
the monitoring and measurement of anesthesia, the electrochemical sensors are de-
ployed, while for the delivery of the drug, the TCI pumps are used. So, what is
missing is the electronic system that controls the overall system, which includes the
controlling of the interaction between the electrochemical sensors and anesthesia
and also controls the TCI pump.
4.2.4 Project Analysis
The next step is design such biosensing platform that addresses the objective
of the research. This platform contains some parts related to the electrochemical
biosensors, also some parts that are for delivering the drug and also some that carry
out the measurement. So, there are several parts that need to be integrated. In
this case, the main challenge is to do the final integration of different parts and
then create a fully working system. Besides that, the design is carried out by two
design teams. So, it is important to optimize the design time and coordination
between the design teams. For this reason, the hardware/software or concurrent
design methodology is adopted during the design of the system.
4.3 Model Implementation
The design of the whole biosensing platform strictly follows the hardware/software
design methodology. In this approach, the hardware and software components de-
sign are carried out in parallel. Since in this project, besides the electronics part of
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the system, there are also the biosensing parts to design. So, there are several parts
that can go in parallel and then are integrated at the end. The following sections
explain how each design step is carried out.
4.3.1 Requirements
Requirements are the starting point in the design process and they include the
information related to the needs of the actual application. In this project, the main
target is to design a biosensing platform that monitors and delivers anesthesia in
real-time. So, in details, the functional and non-functional requirements are follow-
ing:
Functional Requirements
• The system should be able to measure and deliver the anesthesia.
• The system should be able to to process data.
• The system should support Internet of Things (IoT) feature for the transmit-
ting the measurement data.
• The measurement data should be less noisy and reliable.
• The system should be able carry out CA, CV and DPV for anesthesia.
• The system should be easy to use.
• The system should be able to carry out operations in real-time.
Non-functional Requirements
• The system should have low overall cost.
• The system should have high performance in data processing and real-time
operations.
• The dimension and weight of the system should be moderate.
• The system should consume low power, if possible.
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4.3.2 Specification
The specifications bridge the needs of application with designer. So, it is im-
portant to list out all the specifications of the system. They are following:
• The system should include biosensors that can detect the three anesthesia
compounds.
• The system should be able to perform real-time operations.
• The system should be able to perform electrochemical techniques such as CA,
CV and DPV.
• The system should be able to generate and sense signals from biosensors.
• The system should be able to deliver the drugs to the patient.
• The system should carry out the measurement of drugs and delivery in real-
time.
• The system should be able to process the measurement data.
• The system should be able carry out measurements autonomously.
4.3.3 Architecture
Hardware Architecture
According to the requirements and specifications from the previous sections, the
system should contain electrochemical sensors that are suitable for measuring anes-
thesia compounds. It should contain a central control block that is based on a high
performance and low-power micro-controller to perform real-time measurements.
The system should contain a voltage generation block in order to generate the ex-
citation signals required in the electrochemical measurements. The system should
be able to measure the generated current through a sensing block that is interfaced
with electrochemical sensors. The system also needs a process data block and IoT
interface for wireless transmission of data. In order to have a clean measurement
signal, a possible filter block would be useful.
Such functional requirements can be realized with a possible hardware architecture
shown in Figure 4.7.
Software Architecture
The software architecture includes the software operations that are executed in
the hardware architecture. The functional blocks are defined in a way that they can
guarantee a safe operating environment and realize the specifications. A possible
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Figure 4.7: Block representation of the whole system [41]
software architecture can be following as shown in Figure 4.8.
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Filter
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Figure 4.8: Block representation of the software architecture
4.3.4 Components Design
In this step, the hardware and software components are designed in parallel.
The hardware of the whole system is designed using Altium Designer 16 and the
software components are developed and tested in Atmel Studio 7.0.
Hardware Components Design
The hardware design implements step by step each block in the hardware ar-
chitecture.
A) Central Control. The central control block contains the ATXMega32E5
micro-controller [42]. The micro-controller has an internal 32 MHz frequency micro-
processor, a 16-channel/12-bit 300kSPS Analog to Digital Converter, several com-
munication interfaces and high frequency timers.
This micro-controller controls the waveform generation in the actuation block and
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processes the incoming signals from voltage level correction block. It also commu-
nicates with data processing block via I2C interface and exchanges data/command
packets.
B) Data Processing. In this Data Processing block, the RPi is used for
controlling the XMegaE5 micro-controller and also for processing and transmitting
data over WiFi for the IoT Cloud Server. The RPi is the RPi 3 Model B+ and
it contains Quad-core high performance micro-processors. It also has GPIOs that
contain UART, Serial, SPI, I2C and general purpose Input-Output pins. So, it can
communicate with other electronic systems through these available ports. Besides
that, the RPi has Raspbian OS and it can work like a computer and supports
connections with HDMI monitor, the keyboard and mouse. The RPi provides the
Qt software development environment and software applications can be developed
using Qt C++.
In this project, we have used the RPi to connect with the XMegaE5 micro-controller
through its I2C port so that we can exchange data and command packets between
the RPi and micro-controller. Besides that, a Graphical User Interface(GUI) is also
developed inside the RPi and the user can setup the electrochemical measurement
parameters and carry out the desired experiments.
C) Actuation. This block applies a voltage to the electrochemical cells and is
composed of 3 independent DACs with SPI ports. The actuation, or waveform gen-
eration is done by writing to the DACs through the SPI port of the micro-controller.
In this project, the 10-bit MCP4911 DAC is selected and for the OpAmp, the
MAX4475ASA+ is used for the Control Amplifier in the excitation block.
D) Current to Voltage Conversion. The current to voltage conversion is
done through the TIA stage in Figure 4.9 and the MAX4475ASA+ is used for the
OpAmp. In this stage, the current coming from electrochemical cell is converted to
a voltage signal and its DC voltage level is shifted to the half of the supply voltage
in order to avoid the saturation at the output.
E) Sallen-Key Filter. The filtering block includes a 4th order Sallen-Key low
pass filter and it has a cut-off frequency of 200Hz. The 4th order filter is composed
of two cascaded 2nd order Sallen-Key low pass filters and the detailed design of the
filter can be referred to [An IoT Solution for On-line Monitoring of Anesthetics in
Human Serum Based on an Integrated Fluidic Bio-Electronic System.pdf].
This is a unity-gain filter and the input voltage signal amplitude doesn’t change
during the filtering stage. The reason behind using the Sallen-Key low pass filter
is that the filter has a very flat response to the signals in the pass band. We have
decided to use the 4th order filter, as it can give better noise filtering compared to
lower order low pass filters.
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F) Voltage Level Shifting. After the filtering stage, the next step is to adjust
the level of the voltage signal coming from the filtering stage. Because the input
voltage range of the 12-bit ADC of the XMegaE5 micro-controller is from 0 to 2V,
so it is necessary to guarantee that the voltage signal is in this range in order to
get a correct conversion values from the ADC.
The relationship between the generated current at the WE and the measured volt-
age at the input of ADC is following:
Vout = 1.65 + IfRf . (4.3)
Once the Vout is measured, we can obtain the generated current If at the WE and
from the Current-Concentration relation curve, we can obtain the corresponding
concentration of the drug that we are monitoring.
G) Drug Delivery. In the anesthesia monitoring, after the concentration
of the drug in the patient blood is measured through the electronic system, the
next step is to estimate how much dose should be delivered to the patient and the
delivery is done using a TCI pump. In this electronic system, the TMNE-1000
Programmable Single Syringe Pump [43] is used.
The overall electronic hardware of the sensing platform is shown in Figure 4.9.
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Figure 4.9: Schematics of the custom board [44]
Software Components Design
A) Graphical User Interface(GUI). After the hardware setup of the sys-
tem is ready, a Graphical User Interface(GUI) is designed in order to configure
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the electrochemical measurement and data processing. Figure 4.10 shows the steps
included in setting up the GUI during the whole measurement: From the GUI a)
Figure 4.10: Graphical User Interface of the electronic system [41]
we can see that there are three configuration panels that are for Electrode 0, Elec-
trode 1 and Electrode 2. This is because we have three independent electrochemical
measurement channels and they can run in parallel if needed. In each configura-
tion panel, there are three electrochemical techniques that can be chosen for each
channel:CA,CV and DPV.
After the electrochemical technique is chosen for a given channel, the next step is
to set the test parameters for that technique. When the CA is selected, what is
needed to set is the apply voltage value and the sampling interval. When the CV
is selected, the starting and ending voltage, voltage step, step width and starting
point are configured. When the DPV is selected, the starting and ending voltage,
the pulse amplitude, pulse width, pulse period, voltage step and starting point are
configured. The measurement parameters differ from each other depending on the
target drug and also the selected electrochemical sensing techniques.
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After all the channels are configured, the measurement can be started by press-
ing the start button. These test parameters will be sent from RPi to the micro-
controller through the I2C port. During the measurement, the curve of the applied
voltage and generated current is plotted in real-time and measurement results are
received from the micro-controller. Then the measurement can be stopped by press-
ing the stop button. Once the measurement is finished, the received measurement
data are processed and then are stored in Microsoft Excel® files inside the RPi.
B) Central Control. As it is mentioned earlier, the micro-controller is re-
sponsible for controlling the sensing and activation block and also for exchanging
data or command packets with the RPi through the I2C port. So, it is important
to program the micro-controller for carrying out these operations. In the XMegaE5
micro-controller, there are three high frequency timers and they work indepen-
dently from each other. Therefore, they can be used for waveform generation by
sending samples to the three DACs at specific moments through SPI port and for
voltage reading by sampling the input voltages with three ADC channels at desired
moments. The work flow of the micro-controller is shown in Figure 4.11.
As it can be seen, after the initialization of the internal hardware blocks, the
micro-controller remains in the while loop waiting for receiving commands through
the I2C port from the RPi. Once the packets are received from the RPi, the micro-
controller extracts the measurement parameters and configure again the internal
hardware, such as the timer and ADC. Then the measurements start after the start
command arrives and the data packet containing the measurement results will be
sent back to RPi until a stop measurement command arrives.
C) Communication Interface. The RPi exchanges packets with the micro-
controller through the I2C interface. So, it is important to set the data or command
packet format in order to guarantee the reliable and configurable packet transmis-
sion. Here in the below, the packet formats for each electrochemical technique and
measurement data are explained in more details.
D) ChronoAmperometry. The command packet for the CA measurement
parameters is composed of 4 bytes: The set voltage byte contains the voltage value
that needs to be written to the DAC of the corresponding channel for the CA
measurement. The start tag and stop tag are added in order to indicate when the
command packet arrives and when it is complete. The stop tag for all the electro-
chemical measurements is same and it is 0xBB.
E) Cyclic Voltammetry. The command packet for the CV measurement pa-
rameters is composed of 10 bytes: The Start Volt indicates the starting voltage
of the CV measurement, while the End Volt indicates the ending voltage. The
starting point indicates at which voltage value the CV measurement is started so
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Figure 4.11: Work flow of the micro-controller
Figure 4.12: Command packet for CA
that we can start the CV measurement at any voltage value that is supported. The
sweep time indicates how long each voltage step lasts.
F) Differential Pulse Voltammetry. The command packet for the DPV
measurement parameters is composed of 16 bytes: The Start Volt, End Volt and
the Starting Point has the same meaning as the ones in CV. The Pulse Amp indi-
cates the height of the voltage pulse. The Pulse Width shows the duration of each
pulse while the Pulse Period indicates the repetition period of each voltage pulse.
The Volt Step indicates how much the applied voltage increases after each pulse
period time.
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Figure 4.13: Command packet for CV
Figure 4.14: Command packet for DPV
G)Measurement Results. The measurement results are composed of 6 bytes:
They include the applied voltage, measured voltage, start tag and stop tag. The
start tag contains the electrode index mentioned in the following section.
Since there are three independent measurement channels, it is necessary to indi-
cate which measurement channel is selected and what types of operations are to be
executed. Besides that, it is also necessary to indicate whether we need to write
the measurement configuration parameters to the micro-controller or if we want to
read the measurement result from the micro-controller. So, all these operations are
indicated in the Start Tag, which is 1 byte.
Depending on its upper 4 bits, we can select the types of electrochemical mea-
surements.
By setting or clearing the D3 bit, we can indicate whether we want to write
to the micro-controller or read from it. If D3=1, this means the RPi is writing
configuration parameters to the micro-controller. If D3=0, then the RPi wants to
read the measurement result from the micro-controller.
By setting the D2-D0 bits of the start tag, we can choose the measurement channel
we want.
H) TCP/IP based Pump Control. The TMNE-1000 pump is connected to
the RPi through the serial port and it can be controlled through the Qt software
libraries provided by the manufacturer. After the measurement of the anesthesia
compounds, the next step is to evaluate how much dose will be needed to the pa-
tient. The evaluation is done through MATLAB algorithms that models the human
body and estimates the drug concentration in the patient brain in an external com-
puter. After the amount of dosage is known, the value is sent to the RPi through
WiFi using the TCP/IP communication. When the RPi receives the estimated
dosage, it sends this information to the pump via serial port so that the drug de-
livery can be carried out. Figure 4.17 shows the TCP server running on the RPi in
order to receive commands from the MATLAB application running on a laptop.
The Figure 4.18 shows the GUI in MATLAB that is used to communicate with
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Figure 4.15: Data packet for the measurement results
Figure 4.16: Composition of the start tag
the RPi for sending the estimated dosage value to the pump. The MATLAB ap-
plication can receive the real-time measurement values from the RPi, estimates the
dosage needed to be delivered and sends the value back to the RPi.
I) IoT Interface. IoT based applications are being exploited more in the
telemedicine and health care. it is gaining popularity as due to its convenience
and the availability of large scale cloud network servers. The usage of IoT in health
care can give the possibility of data sharing between any devices that are connected
to the network. For example, in the hospitals, the IoT based medical devices can
continuously track the status of the patients and send alarm to the doctors if there
is any abnormal situation on the patient side.
For this reason, we also embedded the IoT capability into our electronic system for
the continuous monitoring of the drugs. The idea is that, the electronic sensing
platform continuously measures the concentration of the anesthesia compounds in
the patient blood and sends alert to the doctors if the traced concentration exceeds
the maximum safety level. This is done by establishing the TCP/IP based wireless
communication between portable android devices and the RPi.
During the measurement, when the test results are received from the micro-controller,
the RPi carries out the data processing and calculates the generated current values
on the WE of the electrochemical cells. Then the calculated current values plus the
applied voltage values are sent together to the portable android device through the
PrYv cloud server. Then the doctor can see the concentration trend of the drug
on the patient. The figure 4.19 shows a typical showcase of IoT based anesthesia
monitoring.
So, it can be seen that, each electronic TDM system can communicate with the
android application of the doctor through WiFi and the measurement results can
be sent to the PrYv cloud server. Then these data can be processed further by
other remote devices that are connected to the server.
On the patient side, the first step is to connect to the PrYv cloud server and allow
data streaming with the doctor. At this point, the electronic system is ready for
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D7 D6 D5 D4 Hex Type
1 0 1 0 A CA
1 1 1 1 F CV
1 1 0 1 D DPV
1 1 0 0 C Stop Measurement
D2 D1 D0 Electrode Index
0 0 0 0
0 0 1 1
0 1 0 2
data and event streaming with other devices connected to the cloud server.
On the doctor side, once a connection request is received from the electronic system
on the patient side, the doctor accepts the connection, authenticates the creden-
tials of the patient and then can start to receive the sensor data from the patient.
There is also a possibility to send alarms to the doctor if the measurement detects
unusual measurement values that are outside the safety range and then the doctor
can carry out necessary steps to ensure the safety of the patients.
Besides connecting to the server on the doctor side, the electronic system of the
patients can also be accessed through remote web applications that are connected
to the cloud server.
With the IoT functionality, the designed electronic system can exchange measure-
ment data and information of the patient with other cloud servers and can enable
the doctors to remotely monitor and diagnose the patients, can be very useful in
telesurgery and other medical services. In the rural areas where the medical con-
ditions are poor, such system can be used for remote diagnostics where there are
insufficient medical specialists for the health-care services [46].
4.3.5 System Integration
After the hardware and software components are designed, the next step is to
carry out the integration of the two parts. In this step, every part of the system
can be tested and debugged individually and also in groups so that possible bugs
or problems can be addressed. An overview of the system is shown in Figure 4.21.
4.4 Experimental Results
In this section, The experimental results are reported for the drug monitoring,
drug delivery and also for the IoT based data transmission tests. The drug monitor-
ing test includes the measurement of the anesthesia compounds. The Drug delivery
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Figure 4.17: TCP Server running RPi
Figure 4.18: The MATLAB GUI for remote controlling of the pump
test includes the injection test of different solutions with the TCI pump. The IoT
based data transmission test includes the data transmission between the RPi and
android devices through the PrYv cloud server.
4.4.1 Test on Drug Monitoring
In this section, the test results for different electrochemical sensing techniques
are reported and test is done on different anesthesia compounds, such as the Parac-
etamol(APAP) and Propofol. Besides that, measurement is done both using com-
mercial sensors and also custom fabricated sensors.
1. Measurement of Paracetamol(APAP)
In this section, the measurement for the APAP is done using the electrochemical
techniques CA, CV and DPV.
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Figure 4.19: IoT based anesthesia monitoring [45]
Figure 4.20: Work-flow charts on the patient and doctor side [45].
The measurements are done in vitro. During the experiment, standard Screen
Printed Electrodes(SPE) from Dropsense (Spain) are used. The measurement is
done by both the electronic sensing platform and also by the commercial Metrohm
Autolab system (PGSTAT 302N) in order to compare and validate the results. The
test parameters used in the following measurement for APAP are shown in Figure
4.22.
1) CA Measurement
In this measurement, the test is performed in PBS pH 7.4 with 10 mM concentra-
tion. The concentration of APAP is increased by [50 - 100 - 150 - 200] µM and
the generated current from the WE is obtained. In this test, the applied voltage is
fixed at 450mV and the measurement results are sampled at 500 ms period. The
measurement results are shown in Figure 4.23.
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Figure 4.21: Sketch of the RPi based electronic system for Anesthesia monitoring
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Figure 4.22: Electrochemical test parameters during the measurements [48]
2) CV Measurement
In this cyclic voltammetry test, the test is done with PBS pH 7.4 with 10 mM
concentration. During the measuremnt, the concentration of the APAP is increased
with the following values in each step: [50 - 100 - 150 - 200 - 250 - 300] µM. At
the end of the measurement, the measurement results are processed with MATLAB
and the peak current values for each concentration of the APAP are obtained. The
test results are shown in Figure 4.24.
3) D V Measurement
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Figure 4.23: ChronoAmperometry test on APAP using Screen Printed Electrodes
[48]
Figure 4.24: Cyclic Voltammetry test on APAP using Screen Printed Electrodes
[48]
In this DPV test, we use again the PBS pH 7.4 with 10 mM concentration and we
increase the concentration of APAP by the values: [50 - 100 - 150 - 200 - 250 -
300] µM. At the end of the measurement for each concentration, the peak current
is obtained. The test results are shown in Figure 4.25.
4) Calibration Curves
After the CA, CV and DPV measurement for the APAP, the calibration curves are
plotted in order to show the relationship between the peak current and concentra-
tion of the drug. The two sets of results coming from commercial Autolab system
and the electronic system are plotted to have the comparison:
From the Figure 4.26, it can be seen that, the calibration curves are quite similar
for the both systems and in CV and DPV measurements, our electronic system has
better sensitivity as the corresponding curves have higher slopes.
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Figure 4.25: Differential Pulse Voltammetry test on APAP using Screen Printed
Electrodes [48]
Figure 4.26: Comparison of the calibration curves [48]
5) Scan Rate Analysis
In order to test the performance of the electronic system, the scan rate analysis is
carried out on CV and DPV measurements. For the CV measurement, the following
scan rate values are tested: [0.16 - 0.11 - 0.09 - 0.08 0.07 -0.06] V/s, while for the
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DPV measurement, the following scan rates are tested: [0.08 - 0.06 - 0.05 - 0.04 -
0.03 - 0.02] V/s, keeping constant the duty cycle at 73.5%. From the Figure 4.27, we
Figure 4.27: Scan rate analysis for CV and DPV measurement of APAP [48]
can confirm that, the Reduction-Oxidation reactions are possible in all the tested
scan rates and there is an increase in the current peak with the increase of scan
rate. From the CV scan rate analysis, we can see that there is a linear relationship
between the peak current and the square root of the scan rate. Therefore, the
reaction of the APAP is a diffusion-control process [49].
2. Measurement of Propofol
In this section, the electrochemical techniques of CV and DPV are carried out
for Propofol and DPV is done for APAP. This time, the measurements are car-
ried out using custom made electrochemical sensors. They are composed of Pencil
Graphene Electrodes (PGE) as the WE, Ag/AgCl as the RE (K0265 105 - diam-
eter 4 mm) and Pt wire from Princeton Applied Research - AMETEK as the CE.
The PGE is disposable and it has excellent electrochemical reactivity that makes
it highly sensitive. It also has very los cost, great mechanical rigidity, wide poten-
tial window, low background current, easy miniaturization and chemical inertness
[50]. The electrochemical sensor used in the electrochemical sensing for the sensing
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platform is shown in Figure 4.28.
Figure 4.28: Pencil Graphene Electrodes [51]
The test parameters used during the CV and DPV measurements are shown in
Figure 4.29.
1) CV and DPV measurements using PGE
In order to characterize the system for the Propofol measurements, the CV and
DPV electrochemical techniques are used for the Profol and the calibration lines
are plotted (current peak versus the concentration).
Besides that, the DPV is done for the APAP in order to characterize how it
behaves at the PGE interface.
2) Scan rate analysis
The scan-rate analysis is carried out in order to test the performance of the system
in fast measurement conditions.
For the fast clearance drugs such as Propofol, the quick responding time of the
system is very crucial. From the scan-rate analysis of CV for the Propofol, it can
be confirmed that, the fouling effect didn’t happen since the oxidation of Propofol
was a diffusion-control process.
From these measurement results, we can confirm that the designed electronic
sensing system can be used for reliable and robust anesthesia monitoring and there-
fore we can ensure a more personalized and safer dosing of anesthesia.
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Figure 4.29: Test parameters for the CV and DPV measurements [47]
4.4.2 Test on Pump Injection
In order to simulate the drug delivery process, the following setup as shown in
Figure 4.32 is designed. The system can reproduce the time trend of a drug con-
centration in a given base volume of an analyzed solution. Through controlling the
injection pump charged with the drug, the RPi can handle the dilution process that
reproduces the PK trend of a drug. With a PK mathematical model in Matlab,
the concentration level is evaluated [52].
In order to validate the system empirically, a dye is used, while the system is
validated through experiments that include sensing the variation of pH and repro-
ducing the Paracetamol trend.
In order to reproduce a concentration time-trend of the Paracetamol in the
patient blood, the injection of dose is done under the continuous dilution of the
base-volume which is executed by a peristaltic flow at a fixed and constant speed.
In order to reach a target concentration, the injection volume of the drug is calcu-
lated using the initial concentration in a volume V with a flow rate Q. Then the
actual concentration of the Paracetamol is measured using CV technique. From
the Figure 4.33, we can see the time-trend of the target concentration and also the
actual concentration. So, the two trends look quite identical in terms of concentra-
tion values [52].
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Figure 4.30: CV and DPV measurement of Propofol and DPV of APAP and the
calibration curves for each measurement [47]
In order to see the change of the concentration visually, we used the green food
dye in the water. The darkness of the green color is different with the different
concentration of the dye in water. So, first the dye concentration is increased pe-
riodically with injection of dye and it becomes more dark. Then the dye solution
is left to be diluted continuously. In this case, the dye concentration decreases in
time and at the end, it becomes light green as shown in the Figure 4.34.
After the experiment with dye solution, the pH change in a given solution is ob-
served. The main objective is to evaluate how the system increases or decreases the
concentration of a drug quantitatively. This time, the distilled water is used as a
neutral solution and the HCI acid is used for changing the pH. In order to measure
the pH variations, we have used a commercial pH meter.
By injecting HCI into the solution, the pH is decreased and corresponding H+ con-
centration is increased. So, the test is done by increasing the ion concentration fast
in time and then leaving it decrease exponentially, as shown in Figure 4.35.
The last test with the flow-injection setup is done with Paracetamol(APAP). First
the concentration of the APAP is increased in steps by injection and the APAP is
left to dilute with time. Since the concentration of APAP can be measured using
the PGE, the change of the concentration in time is plotted, as shown in Fiture
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Figure 4.31: Scan rate analysis for CV and DPV measurement of Propofol and
DPV of APAP [47]
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Figure 4.32: Experimental setup for the injection test with TCI pump [52]
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4.4 – Experimental Results
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Figure 4.33: Example of the dose injection [52]
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Figure 4.34: Dye test with TCI pump [52]
4.36. In this way, we can characterize the drug delivery system and identify the
trade-offs between the drug injection speed, the peristaltic flow speed and the stir-
ring condition of the system.
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Figure 4.35: pH test: dose injection and measurement of concentration [52]
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Figure 4.36: APAP test with TCI pump [52]
4.5 Discussion and Conclusion
In this chapter, an embedded electronic sensing platform has been presented
for the anesthesia monitoring and delivery. The system is capable of detecting
simultaneously and independently the compounds of anesthesia throu h different
electrochemical techniques. The system has high sensitivity, fast response to the
change of the concentration of the drugs.
The electronic part of the system consumes low power and is around 390mW.
The design of the electronic part has followed strictly the embedded system design
methodologies and the smart data analysis is realized in the firmware of the system.
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The overall cost of the system is less than 150$ and its size is 27 x 21 x 13 cm, and
is portable. So, compared to the commercial Autolab system mentioned earlier,
the has more advantages in terms of cost, sensitivity and portability. Besides that,
with the IoT functionality, the presented system can have greater applications in
telemedicine, remote patient monitoring and in smart hospital design.
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Chapter 5
Portable Memristive Biosensing
System for Cancer Diagnostics
5.1 Introduction
5.1.1 Prostate Cancer
The prostate is a gland with a walnut-size in the male reproductive system and
is located below the bladder and in front of the rectum. The prostate cancer takes
place in the prostate gland and it is a malignant tumor that is caused by the un-
controllable growth of the cells in the prostate gland.
The prostate cancer is a very common type of cancer and causes large number of
death among men every year. The table 1.1 reports the predicted death rate of
men due to the cancer and it can be seen that the predicted rate for the prostate
cancer is around 10.6/100,000 in 2016, which is the third among men in Europe [53].
Table 5.1: Cancer related mortality [53]
Cancer type Deaths in 2011 Predicted deaths in 2016
men
Lung 185,707 183,800
Colorectum 90,412 95,600
Prostate 72,330 75,800
Pancreas 39,056 42,600
women
Breast 91,291 92,300
Lung 79,474 89,700
Colorectum 77,478 77,800
However, if the prostate cancer is detected in its early stage, it can be cured.
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So, it is important to detect the cancer in its early stage. One of the most common
method for detecting the prostate cancer is through using Prostate Specific Antigen
(PSA). PSA is a 30 kDa kallikrein protein and is produced by cells of the prostate
gland. it is one of the main cancer marker for prostate cancer.
5.1.2 Therapeutic methods for Malignant Diseases
In order to treat the prostate cancer, some of the common treatment methods
are as follows: first, there is the active surveillance, then the surgery, radiopharma-
ceutical therapy and radiotherapy, chemotherapy, hormone-therapy and biophos-
phonate therapy. The drug treatment can be also an effective but chemically very
invasive therapeutic approach, and is also called as chemotherapy. it is mostly used
for the malignant disease treatment, such as the HIV and cancer. The drugs used
in these cases are very toxic with severe side-effects, so the monitoring of these
drugs is extremely critical.
In the treatment of prostate cancer and HIV, the Etoposide is one of the most
commonly used drugs. However, the precise monitoring of the etoposide is very
important as it has an effective therapeutic range and it ranges from tens of µM to
several hundreds of µM [54][55], [56]. While a small portion of the drug is effective
for the cancer, the remaining part goes to the other organs in the body and creates
very undesirable side-efects cush as hepatotoxicity, alopecia, myelosupporession,
leukopenia, cardiomyophathy and so on.
Besides the atoposide, the Tenofovir is also another antiretroviral agent for treating
the HIVD1 infection [57]. Its main function is the termination of the chain and it
follows intracellular phosphorylation to triphosphate form and prevents the DNA
from elongation and the HIV from multiplication. The therapeutic range of Teno-
fovir is from some nM to 860 nM.
The therapeutic drug monitoring is one of the mostly adopted therapeutic ap-
proach and it monitors the drug concentration over time in a closed loop system
of the patient and aims at maintaining the concentration of the drug in the ef-
fective therapeutic range. This is a patient dependent approach and is based on
the characteristics of the patient, and is also based on the drug characteristics
used in the chemical treatment. So, it is very complex, has uncertainties when
implemented, adopts invasive sample and require the detailed knowledge on the re-
lationship between the profile of proteins and the responses of drugs. So, a cutting
edge Point-of-Care approach is needed in order to address these problems existed
in the drug monitoring.
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5.1.3 Nanotechnology in Diagnostics and Therapeutics
Nanotechnology is drawing more attention of the researchers these years and is
the combination of technology, science and other research fields. Its applications
are exploited in many areas in the last ten years and in the medical field, nan-
otechnology is playing more important roles such as providing new approaches for
clinical therapies and also for diagnostics [58][59][60].
In the nanotechnology, materials with nanometer scale are created or manipulated
and these materials have comparable sizes to proteins, viruses, cells and other bi-
ological molecules. This offers a highly accurate sensing methods and it can be
extremely useful for the detection and monitoring of the cancer. Therefore, these
materials with nanostructures can be ideal candidates for high-sensitive biosen-
sors. Such creation and manipulation of nanomaterials is possible thanks to the
development of CMOS technology and small scale, low cost and sensitive, nanoscale
biosensors can be produced and used in the medical applications, especially in point
of care diagnostics, personalized medicines and self-diagnostics applications [61].
5.1.4 Memristive Phenomena
In the nanoscale, the nanostructures exhibit many interesting properties and
some of them also show the hysteretic electrical property, also called the memsris-
tive phenomena. This phenomena is an important and unique signature of memory
devices and such devices are also called memristors.
The memristor is first presented by L. Chua in 1971 as a fundamental passive cir-
cuit element with two terminals [62]. Its resistance depends both on its previous
state and its present electrical conditions. The memristor is mathematically de-
fined as a current-controlled device characterized by the memristance (M). For the
linear elements, the memristance is constant and is same to the resistance. But
when the memristance is dependent on the charge flowing through it, then in this
case the memristance corresponds to a nonlinear circuit element and behaves like
a resistance with memory and shows a frequency dependence, which is one of the
key properties of memristive systems.
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Figure 5.1: Four fundamental circuit variables (a) [63] and the hysteresis curve of
a memristor (b) [63]
The mathematical expression for the memristor is following:
u = R(ω)i (5.1)
dω
dt
= i (5.2)
The u represents for the voltage and the i represents for the current. The ω is the
state variable and the R represents the generalized resistance that is dependent on
the state of the device.
Such memristance can have many potential applications in the design of memory
devices, logic circuits [64], artificial synapses [65][66][67][68] and Resistive RAM
memories [69].
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Figure 5.2: Applications of memristive structures ref to [68][70]
5.1.5 Memristive Biosensors for Cancer Detection
The nanobiosensing applications are attracting more attention as they provide
real-time monitoring with minimally invasive approaches in the preventive treat-
ments and personalized therapies [71]. Particularly, the one-dimensional silicon
nano-wires can be best candidates for bio-sensing applications thanks to their quan-
tum properties and large surface-to-volume ratio [72]. Furthermore, some of the
nanofabricated devices such as the silicon nano-wires demonstrate the memristive
phenomena mentioned in the previous sections [73]. The memristive effect is depen-
dent on the rearrangement of the charge carriers at the nanoscale which is caused
by the external perturbations [73]. In the recent studies, the possibility of creating
such memristive silicon nanowires by combining modulated-gate nanowire transis-
tors and redox active molecules is reported [74]. So, a novel-type molecular sensing
using memristive nanowires functionalized with the bio-molecular thin films in dry
condition is reported in literature [75].
In Figure 5.3 it is shown that the electrical response of the memristive nanowires
before and after bio-functionalization is different and this can be used for the ultra-
sensitive molecular detection [14], and also for the early stage prostate cancer de-
tection [76].
95
5 – Portable Memristive Biosensing System for Cancer Diagnostics
Figure 5.3: Hysteresis response of the memristive nanowires before (1) and after
(2) the bio-functionalization [77]
In the curve (1), the voltage difference, also called voltage gap that corresponds
to the current minima is zero, while after the bio-functionlization, in the (2), the
voltage gap increases due to the gate modulation of the nanowire transistors from
antibody charges [77].
5.1.6 Research Objective
The biosensors are devices that convert biochemical signals to measurable elec-
trical signals. Therefore, they need to be combined with proper electronic systems.
These electrical signals can be a current, voltage, temperature, humidity, capaci-
tance etc. This is largely dependent on the type of biosensor due to their specificity.
So, the bio/CMOS interface is also specific for a given type of biosensor.
As it is explained before, the memristive biosensors exhibit the electrical response
for the externally applied voltage and the memristive property can be used for the
molecular detection. So, an electrical interface that stimulates the biosensors and
senses the generated current would be necessary in order to relate the detection of
molecules with the hysteresis. Besides that, the generated current signal needs a
signal conditioning circuity and then finally a signal processing block for the quan-
titative analysis of the measurement. So, the research objective is to design an
embedded biosensing platform for cancer detection.
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5.1.7 Project Analysis
In this project, the target is to develop an embedded biosensing platform for
memristive biosensors and carry out some tests on cancer detection. So, it is impor-
tant to follow a proper design flow during the implementation. The final system will
contain parts related to electronics and also parts related to the memristive biosen-
sors. Besides that, the system will also need some software functionalities to carry
out some data processing and calculations. So, the design of these parts can be
done in parallel and a final working system that could meet the basic requirements
of the test for the detection of cancer could be sufficient. So, the hardware/software
design methodology can be a good choice for the parallel design and also for coor-
dinating between different research groups.
5.2 Model Implementation
In the hardware/software design methodology, the parts related to the hard-
ware and software components design can be carried out in parallel. This section
describes the implementation of each step and presents a fully working system at
the end.
5.2.1 Requirements
The first step in the design is to find out the functional and non-functional
requirements related to the project.
Functional Requirements
• The system should be able to interface with 12 memristive biosensors for
applying the stimulation signals and sensing the generated currents.
• There are 12 memristive biosensors in each measurement.
• The memristive biosensors should have common stimulation signal from the
system.
• The system should be able to provide the signal conditioning circuitry for the
generated currents.
• The system should be able to process the output signals from the conditioning
circuit.
• The system should be able to analyze the data in a given time.
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• The system should be able to forward the data to remote servers if necessary.
• The measurement data should be clean and less noisy.
• The system contain a graphical user interface that can setup test parameters,
start and stop operations and display the measurement data if necessary.
• The design time of whole system should not be very long.
Non-functional Requirements
• Performance: The timing requirement for a biosensing platform is important
as it is related to how fast the system can cope with the biosensors in order
to carry out a specific operation, how fast the acquired signals are processed
and the data is analyzed, etc.
• Cost: The cost during the design of an electronic system is one of the impor-
tant parameters that need to be taken into consideration from the manufac-
turing point of view and also from the design point of view.
• Weight and Dimension: The dimension and weight of an electronic system
affect the usability of the system and they are mainly dependent on the type
of the application. The dimension and weight of the system are very critical if
when the system needs to be implanted inside the subject. The weight of the
system also limits the usability or portability of the system in many scenarios.
So, a careful design of the system with a proper dimension and weight is very
important.
• Power Consumption: In the battery-powered applications, the power con-
sumption is of the dominant factors that decide the lifetime of the system for
a normal operation. For example, in the implantable electronic systems, it is
not feasible to change the battery so often and it is very important for the
system to be power efficient. In the applications where a portable electronic
system is preferred, the power consumption is also very a important factor to
be considered.
5.2.2 Specification
After the requirements from the application are listed, the next step is to spec-
ify in more details what the system functionalities and performances. The system
has to have a connection interface to connect to a 12 V power adapter. It has to
initialize all internal hardware after it is powered on and enter an idle mode for
receiving commands from the serial port managed by the graphical user interface
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(GUI) running in PC or other types of Embedded Computers. The GUI has to pro-
vide options for setting test parameters, starting and stopping the test operations,
setting up, opening and closing the serial port. The GUI should display the test
results if necessary and it has to process the data automatically. The signal condi-
tioning block of the system has to process the generated signals from the biosensors
and the system has to a data conversion block that can sample the signals from all
the 12 memristive biosensors simultaneously or sequentially.
5.2.3 Architecture Design
After the specification step, there is the architecture design step that specifies
how the system has to implement the requirements and specifications. The ar-
chitecture design is composed of hardware architecture and software architecture
design.
Hardware Architecture
So, the electronic system was designed to have the following hardware blocks to
implement the required operations: 1) a mechanical block that interfaces the mem-
ristive biosensors with the rest of the system; 2) a block sensing and actuating the
signals for the biosensors; 3) a functional block that can control the overall hard-
ware; 4) a block for serial port communication; 5) a block for smart data analysis;
6) a block for cloud IoT interface for transferring the data. A possible hardware
architecture can be as following as shown in Figure 5.4.
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Figure 5.4: Hardware architecture of Memristive Biosensing Platform
It can be seen from Figure 5.4 that the biosensing platform is composed of two
main blocks: 1) biosensing control and 2) Post processing block. The biosensing
control block contains central control, biosensor holder, sensing and actuation, and
finally the serialport and storage sub-blocks. The Post processing block is com-
posed of cloud IoT interface and smart data analysis sub-blocks. A more detailed
hardware architecture is shown in Figure 5.5.
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Figure 5.5: More detailed hardware architecture of the system
In the biosensor holder block, it is present a mechanical holder that hosts the
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memristive biosensors and interfaces them to the rest of the hardware. In the sens-
ing and actuation block, the signal conditioning block is responsible for processing
incoming signals from the biosensors. The DAC and doubling block generates
stimulation signals and amplifies by a factor of two. The Mux and ADC block
multiplexes between 12 memristive biosensors and carries out measurements se-
quentially for each of them.
The central control block contains the micro-controller that executes software oper-
ations and also controls other blocks. The H-T sensor block is useful for measuring
humidity and temperature, while the voltage regulators block shall regulate the
input voltage and then powers up the rest of the hardware blocks except the data
processing block.
It is present a local storage block that contains a µSD Card holder for storing (in
off-line mode) the measured data and the serial port block will be dedicated to
the communication with a PC or an embedded computer. The data processing
block post processes the data and forwards the data to IoT cloud server wirelessly.
There is also a data visualization block that can plot the processed data if necessary.
Software Architecture
The software architecture contains the software blocks needed for the carrying
out the operations of the system. A possible architecture is shown in Figure 5.6.
DAC
Central
Control
T & H
Sensor
Mux & ADC
TimerGUI
Data
Processing
SPI
I2C UART
Could IoT
UART
SPI
I2C
SPI
Figure 5.6: Software architecture of the system
In the software architecture, the central control block communicates with Graph-
ical User Interface (GUI) block via the UART library, transmits data packets and
receives test commands. It communicates with MUX and ADC block through SPI
library, selects the input signal for ADC, triggers the conversion and then reads
back the converted digital data. It communicates with DAC block via SPI library,
writes digital samples to it to generate analog voltage signal. It communicates
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with Humidity and Temperature block via I2C interface, reading the humidity or
temperature of the environment. It sets up the timers for periodic operations.
The GUI block contains the control panel for setting up the experiment and sends
the parameters via UART port to the central block. It also receives the measure-
ment data from central block, processes it and sends it to the Cloud server if needed.
5.2.4 Components Design
The components design step implements the blocks in the architecture design
step and it contains hardware components design and software components design.
Hardware Components Design
A) Central Control. This block contains three sub-blocks: Micro-controller,
H-T Sensor Module and Voltage Regulators. For the Micro-controller, the high
performance STM32F446RE Micro-controller is selected. This micro-controller can
reach 180 MHz frequency and it has 16 internal counters. It contains various
types of communication interfaces, such as I2C, SPI, UART, etc. The H-T Sensor
Module is composed of HDC1050DMBT and it is useful for measuring the envi-
ronment humidity and temperature during tests. The voltage regulators produce
different levels of output voltages: 2.5 V, 3.3 V, 5 V and 10 V. The 2.5 V is gener-
ated by ADR3425ARJZ as the 16-bit high resolution Digital to Analog Converter
AD5686RBRUZ in the DAC & Amp block needs a highly stable 2.5 V reference
voltage. The 3.3 V is generated from LD1117DT33 chip and it is supplied to the
micro-controller. The 5 V is generated from LM22674MRE-5.0 chip and is supplied
to operational amplifiers in the signal conditioning block. The 10 V is generated
from MCP1804 chip and is also supplied to the signal conditioning block.
B) Biosensor Holder. The biosensor holder contains a sensing chip that
includes 12 silicon nanowires with common excitation and independent outputs
connected to the signal conditioning block. The biosensor holder has a dimension
of 20x20 mm and it also has a connector that interfaces it to the signal conditioning
block. The biosensor holder is shown in Figure 5.7.
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Figure 5.7: Chip holder board [78]
C) Sensing and Actuation. This block contains three sub-blocks: signal
conditioning, mux & ADC, DAC & Amp. The signal conditioning block takes the
input current from biosensor holder block, then converts the current to voltage
through a transimpedance amplifier and then gives it to the Mux & ADC block.
The detailed schematics of the signal conditioning block is shown in Figure 5.8.
Figure 5.8: Signal conditioning front end [78]
The OpAmp is AD8641 and it has an input bias current of maximum 1 pA The
signal conditioning block has in total 12 outputs correspondent to the memristive
nanowires.
The Mux & ADC block takes inputs from the signal conditioning block. For the
Mux ADG428BRZ is used while for the ADC, the 20-bit AD7785BRUZ chip is
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used. The Mux selects sequentially each signal conditioning output, then the sig-
nal is converted inside ADC and is then read by the micro-controller in the central
control block.
The DAC & Amp block is composed of AD5686RBRUZ and AD8641 chips. it is
possible to generate very accurate stimulation signal thanks to the 16-bit DAC.
D) Serialport & Storage. This block is dedicated to the serial port commu-
nication and local data logging in the µSD Card. The serial port is composed of
FT232 Module that converts UART to USB, while the µSD Card holder supports
the microSDXC card (64 GB, SDCA3, speed class 10) for storing local data.
E) Post processing. The post processing block is composed of two sub-
blocks: data processing and visualization. For the data processing and visualiza-
tion, the high-performance Raspberry Pi (RPi) 3 is used. It communicates with
the STM32F446RE micro-controller through the serial port block. The RPi has
integrated WiFi chip and it supports IoT applications.
Software Components Design
This section describes in details the design of the software blocks that run inside
the STM32F446RE Micro-controller and RPi 3.
A) GUI. The GUI is designed in order to make the system easy to use and
flexible. It is developed in Qt Creator 5.3 using C++ and it runs inside the RPi 3.
It is shown in Figure 5.9.
Figure 5.9: GUI for controlling the measurement
It contains parameters related to the test such as: start voltage, stop voltage,
step voltage and sweep time or step width. After the parameters are set, they are
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sent to the STM32 micro-controller via serial port and then the micro-controller
can configure the internal hardwares such as the timer, ADC and DAC for the test.
B) Central Control. This block initializes all the hardware and software
inside the micro-controller and the work flow of the central control is shown in
Figure 5.10.
while(1)
Initialization
Read
Serialport
Start Flag==1?
Index=Index+1
Update 
 DAC Value
Polarity>0?
Index=Index-1
Index>MAX? Index<0?
Polarity=-1 Polarity=1
Read ADC
Write to DAC
Read Flag==1?
Yes
Yes
Yes
Yes Yes
No
No No
No
No
Figure 5.10: Work flow of the central control block
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From the Figure 5.10 it can be seen that, after the initialization of hardware
and software components, the central control block enters a continuous while loop.
First, it reads the serial port to see if there is any data packet arrived from the
external GUI. If yes, then it parses the data packet, extracts the commands and
test parameters. If it is the start command, then the Start Flag is set to 1 and
measurement on biosensors starts. If it is the stop command, current ongoing mea-
surement will stop. After the start command is received, the central control block
writes to the DAC block to generate the stimulation voltage. Then it checks the
Read Flag. If the flag is set, then the digital value from ADC block is read and sent
to serial port. After that, according to the polarity flag, the index that decides the
digital value of DAC will increase or decrease and a new DAC value is calculated
for writing to the DAC chip. Then the loop repeats until the stop command is
received from serial port. Here the timer library controls the read and polarity flag.
C) DAC. This software library controls the generation of stimulation voltage
via write to the DAC chip. The stimulation voltage range is from 0 to 2.5 V, then
after the amplification circuit with a gain of 2, the final output voltage has a range
of 0 to 5 V. Besides that, outputs of the biosensor chip are referenced at 2.5 V.
Therefore, it is possible to apply a voltage sweep in the range of ±2.5 V between
common source and individual drain on the biosensor chip shown in Figure 5.7.
The relationship between the digital value and actually generated voltage at the
output of the DAC chip is following:
Vout =
D
65535 × 2.5(V ). (5.3)
The maximum value 65535 corresponds to the 2.5 V and after amplification, it is 5
V. So, the actual applied voltage difference between the source and drain terminal
of the biosensor is:
Vout = (
2D
65535 − 1)× 2.5(V ). (5.4)
The writing value and its duration can be precisely controlled through the timer
library during the voltage sweep and the applied voltage to the biosensors has the
following profile shown in Figure 5.11.
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Figure 5.11: Voltage sweep during measurement
D)Mux & ADC. The multiplexer is controlled by writing to the corresponding
gpio pins of the micro-controller so that desired signal conditioning channel can be
selected for signal sampling. The ADC is configured as bipolar with Gain equal
to 1 and external 5 V reference voltage. The ADC is controlled through the timer
library and it samples when the timer triggers it. The output results are 24-bit
and the upper 4 bits are neglected. The output coding is calculated through the
following equation:
Code = 2N−1 × [(V in× GAIN
VREF
) + 1]. (5.5)
In our case, the N is equal to 20, the VREF is 5 V, and Gain is set to 1. So, from
the output result, it is possible to calculate the input voltage:
V in = ( D524288 − 1)× 5(V ). (5.6)
E) Data Processing. The data processing block is dedicated to the inverse
calculation of the generated current on each biosensor from applied voltage and
then to find out the voltage gaps described in previous sections. This block is part
of the GUI application inside RPi 3. The applied voltage is calculated from 5.4
and measured voltage is calculated from 5.6. The generated current is calculated
according to the input output relationship of the signal conditioning hardware
block:
sensor_current = −( 470× 234.5471× 233.5× 2.5−
measured_voltage
233.5 )×5×10
4(pA). (5.7)
After the sensor current is calculated, then the logarithmic value of its module is
calculated:
LogI = log10(Abs(sensor_current)). (5.8)
Then the Applied_voltage vs. Log_I graph is plotted and the voltage gap is ob-
tained at the two minimum Log_I values. This will be shown in the experimental
results section.
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5.2.5 System Integration
The next step is to integrate the whole system and carry out tests and de-
bugging. The first prototype of the biosensing control system is shown in figure
5.12.
Figure 5.12: The first prototype of biosensing control system
The post processing block is composed of a RPi and a uart to serial converter.
So, the final system is shown in Figure 5.13.
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Figure 5.13: The complete memristive biosensing platform
The RPi can be accessed through NX Server via ethernet connector from PC,
so there is no need for additional monitor, keyboard and mouse. The next sections
present the test results and validate the design.
5.3 Experimental Results
After the complete system is ready, the next step is to carry out experiments on
the fabricated memristive biosensor chips. Initial test is carried out on bare mem-
ristive nanowires that are newly fabricated. Then there is the antibody printing
step followed by the antigen detection step.
5.3.1 Test on Silicon Nanowires
In this test, the silicon nanowires do not yet have any antibodies on top of
them and the test is simply the current to voltage response. It demonstrates the
memristive hysteresis properties shown in Figure 5.14.
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Figure 5.14: Hysteresis curve of the bare memristive nanowire chip
In this test, the start voltage is -0.8 V, the end voltage is 0.8 V, the step voltage
is 0.2 V and the step width is 1 second. Besides the hysteresis curve, we also have
the curve of the applied voltage and logarithmic current module shown in Figure
5.15.
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Figure 5.15: Voltage gap of the bare memristive nanowire chip
In the voltage gap curve, it is obvious that for the memristive nanowires before
bio-functionalization, the voltage gap is almost zero. The hysteresis curve is also
not very flat near the origin.
5.3.2 Test on Antibody-based Memristive Biosensors
In this test, the memristive nanowires go through the antibody printing. This
process will change the electrical response of the silicon nanowires and we observe
different hysteresis curve shown in Figure 5.16.
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Figure 5.16: Hysteresis curve of the bio-functionalized memristive biosensor chip
Besides that, the voltage gap curve is also different shown in Figure 5.17 and the
voltage gap is close to 0.34 V. So, the antibody has changed the hysteresis property
of the silicon nanowires on the chip holder and this is related to the change of Debye
Length on the surface charges on the nanowires.
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Figure 5.17: Voltage gap of the bio-functionalized memristive biosensor chip
5.3.3 Test on Prostate Specific Antigen (PSA)
In this test, the Prostate Specific Antigen (PSA) is used as a cancer marker of
Prostate Cancer and two different concentrations 3.3 fM and 330 fM are tested. The
voltage gap in the logarithmic curve of the current changes with the concentration
of the antigen and by using the calibration curve that relates the voltage gap and
concentration of the PSA or other antigens, it is possible to obtain the concentration
from voltage gap values. In this test, first a PSA concentration of 3.3 fM is tested,
then 330 fM is tested. The comparison of the hysteresis is shown in Figure 5.18.
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Figure 5.18: Comparison of hysteresis for 3.3 and 330 fM PSA
In Figure 5.19, the two voltage gaps are compared with each other and it is
expected to have a decrease in the voltage gap with respect to the increase in
concentration and the assumption is validated in the test.
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Figure 5.19: Comparison of voltage gaps for 3.3 and 330 fM PSA [78]
5.4 Discussion and Conclusion
Here we discuss the results and conclude. In this chapter, a novel memristive
biosensing platform is presented. The design of the system has followed hard-
ware/software concurrent design methodology and the overall design time was op-
timized thanks to this approach. The system was designed in order to optimize
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the measurement process. Previously, the Cascade Microtech Probe Station and
a Hewlett-Packard 4165A Precision Semiconductor Parameter Analyzer were used
for sensing and actuating the memristive biosensors during the measurement and
the measurement time was around 40 minutes for 16 memristive nanowires, ap-
proxiamately 3 minutes for each of them and the test was done manually [76][78].
Now, the whole test for 12 memristive biosensors takes around 3 minutes. Further-
more, the test is controlled flexibly and the data processing is done automatically
in the GUI in a smart way. The calculation of voltage gaps is also done within the
software and at the end of the test, the voltage gaps are available as final results.
it is also possible to see how the memristive biosensors respond to the stimulation
and their electrical behavior can be monitored in real-time during the test [76].
Besides that, the designed embedded system is portable, consumes low power, can
be powered by a battery and costs around 200$ which is much cheaper compared
to the prices of the commercial probe station and parameter analyzer used in the
previous research. So, this is a very novel biosensing platform that can be very
useful for the early stage cancer detection thanks to the ultra-high sensitivity of
the memristive biosensors [14] and also thanks to the automatic and easy-to-use
embedded biosensing platform.
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Chapter 6
General Purpose Biosensing
Platform Design
6.1 Introduction
In health care research and promotion and delivery, the main aim is to assess
disease progression, health status and monitor the outcome of a treatment by us-
ing a non-invasive method. It requires three preconditions in order to achieve this
goal: specific biomarkers that can indicate healthy or diseased states; a possible
non-invasive approach for detection and monitoring the biomarkers; and finally the
technology for discriminating biomarkers [79].
6.1.1 Biosensors in Health Care
Biosensors are being widely used in medical diagnostics and scientists are car-
rying out extensive research in developing innovative technologies and newer tools.
Since the biosensors have immense potentiality in medical diagnostics, as they are
simple in operation, they have high sensitivity, they could perform multiplex anal-
ysis, and they are capable of being integrated into the same chip with different
functionality [80].
Biosensors can be categorized into different groups based on their transduction el-
ement or biological element. The biological elements can be antibodies, enzymes,
biological tissue, organelles and micro-organisms.Depending on their transducer el-
ements, the biosensors can be piezoelectric, optical and electrochemical types [81].
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6.1.2 Definition and Characteristics of a Biosensor
A biosensor is described as an analytical device that is used for detecting chem-
ical substances and converts a biological signal to a processable and quantifiable
signal.
Generally, every biosensor is composed of a biological component that senses
the substances of interest and an electronic component that captures and transmits
the biological signal [82].
A biosensor can be composed of the following parts, as shown in Figure 6.1 [83]:
• Analyte: A substance that needs to be detected. For example, in a glucose
biosensor, the ’analyte’ is the glucose.
• Bioreceptor: A molecule that recognizes only a specific type of analyte.
• Transducer: It is an element that is dedicated to converting an energy from
one type to another. The role of it in biosensor is to convert the biologi-
cal signal into a measurable signal. The signals can be electrical or optical
depending on the type of transducers.
• Electronics: It is the part that is used to process the signal coming from the
transducer and to prepare it for post-processing or display. It is composed of
electronic circuitry that carries out signal conditioning and conversion.
• Display: This part is used for quantifying the processed signals coming from
electronics. The display can be graphic, numeric, an image or tabular, de-
pending on the actual output requirements of an application.
The typical characteristics of a biosensor [83] are:
• Selectivity: The selectivity is defined as the ability of a biosensor in detecting
a specific analyte in samples that contain other contaminants and admix-
tures. A good example can be the interaction of an antigen with an antibody.
The antibodies are bioreceptors immobilized on the surface of the transducer.
When the antibody is introduced into a solution that contains the antigen,
then it interacts only with the antigen. So, during the construction of a
biosensor, the main consideration in choosing the bioreceptors is the selectiv-
ity.
• Reproducibility: This the ability of a biosensor to show identical responses
for a duplicated experimental set-up. In a biosensor, reproducibility is char-
acterized by the accuracy and precision of the transducer plus electronics.
Reproducibility plays an important role in providing robustness and high re-
liability in understanding the response of a biosensor.
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Figure 6.1: Internal blocks of a biosensor [83]
• Stability: It is defined as the degree of susceptibility of the biosensor to the
ambient disturbances. The output signals of a biosensor could be subject to
a drift due to these disturbances, which results in erroneous measurement
in concentration and will affect the accuracy and precision of the biosensor.
it is very crucial for a biosensor to be stable in continuous monitoring or in
situations where the biosensor would long incubation steps.
• Sensitivity: It is also called the limit of detection (LOD) and it is defined
as the minimum amount of analyte a biosensor could detect. In many envi-
ronmental and medical applications, the biosensor is required to have a very
high sensitivity in order to confirm if a sample contains possible analytes. For
example, in the early stage prostate cancer detection, the doctors will suggest
biopsy tests for a prostate-specific antigen (PSA) concentration of 4ng/ml in
blood.
• Linearity: It is an attribute linked to the range of analyte concentrations
and resolution of biosensor under test. The resolution of a biosensor can be
understood as how much change in the analyte concentration could cause a
change in biosensor response. The linearity of a biosensor is required in order
to guarantee that the biosensor works in a wide range during the measurement
of analyte concentration.
6.1.3 Electronics for Biosensors
In a biosensing platform, the transducer or biotransducer converts the biologi-
cal or electrochemical changes into a detectable electrical signal. Depending on the
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type of biotransducer, the electrical output signal can be different. In electrochem-
ical sensors, the electrochemical changes that are taking place on the surface of the
electrodes that are interacting with the analyte. These changes can be amperomet-
ric, potentiometric or conductometric. So, the output signals are current, voltage
or conductance. In optical sensors, the electrical signal that changes is the prop-
erties of light, which can be correlated with the changes in concentration, mass or
molecule number in the cells. In piezoelectric sensors, the output of the transducer
is the resonant frequency of the crystal which results in an oscillating voltage that
can be tracked by an acoustic wave sensor. In thermal or calorimetric sensors, the
output signal is the temperature and by measuring it, the concentration of analytes
can be determined.
In order to carry out the measurements on the current, voltage, conductance, tem-
perature or other electrical signals, an electronic system would be necessary and
it would perform different operations such as amplification, filtering, level shifting,
attenuation, conversion, linearization, electrical isolation, excitation, etc.
In different biomedical applications, one might find different electronic systems that
are specific to the selected biosensors. For example, let us consider three biosensing
platforms based on different biosensors: 1) a point-of-care memristive biosensing
platform is developed for the early stage cancer detection [78] 2) an electrochemical
sensor based biosensing platform is presented for on-line monitoring of anesthesia
in [44] 3) A flexible biosensing platform for wearable electrochemical sensing [84].
In all the three applications, there are different biosensors or sensors, such as mem-
ristive biosensor, electrochemical sensor and ion-sensitive biosensor. The custom
electronic system developed for each sensor cannot be shared with each other and
no standard interface which allows the interconnection between the sensor and elec-
tronic platform is available. Therefore, if there is a need to develop a biosensing
platform for another type of sensor or biosensor, the electronics that conditions
the signal, processes it and processes and displays the data will be different and
has to be designed from scratch and none of the three electronic parts of the three
examples could be used due to the lack of the compatibility between each other.
6.1.4 Hewlett Packard Interface Bus (HP-IB)
In 1960s, the Hewlett-Packard (HP) had the similar problem of interconnec-
tion between its wide range of products, as when different products needed to be
connected to each other, they suffered problems related to the electrical, mechan-
ical functional and hardware compatibility [85]. So, the HP developed a Generic
Purpose Interface Bus (GPIB), also called HP-IB in order to facilitate the inter-
connection between various controllers and instruments Later it was defined as a
standard digital interface, named IEE-488 [86]. The communication protocol be-
tween devices connected with GPIB is defined by the IEEE-488 and the GPIB
connector contains 24 pins that contain address, data, command, clock and power
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lines. Different devices can be connected to a same host controller through this bus
which acts as a simple and standard hardware interface.
6.1.5 Research Objective
Similar approaches can be adopted in order to make the interconnection possible
between different types biosensors and a same signal processing hardware platform.
So, there is a need to develop an electronic platform that provides a standard in-
terface bus and supports any kinds of sensors or biosensors. In order to design such
general purpose electronic platform, it is important to find out first the general
characteristics of biosensing platforms. As previously mentioned, in a biosensor,
the the bioreceptor is specific to a given type of analyte. The transducer converts
the biological signals coming from bioreceptors into electrical signals. The output
of the transducer can be electrical or optical depending on the transducer. The
electronics processes the electrical or optical signal and provides relevant informa-
tion on the measurement.
Among these different components, it is hard to generalize bioreceptor due to its
selectivity. The transducer can also be hard to generalize as it is difficult to design
a general purpose transducer that can convert any types of biological signals into
a given type of electrical signal. However, the electronics that is responsible for
signal conditioning and processing can be generalized, because the output signals
of the transducer can be converted into a single type of electrical signal such as a
voltage signal through specific electronic circuitry. For example, a current signal
can be converted into a voltage signal through a current to voltage conversion. A
frequency signal can can be converted into a voltage signal through a frequency
to voltage conversion. An impedance signal can be converted to a voltage signal
through a voltage division. A temperature signal can be converted to voltage signal
through a temperature to voltage converter, etc.
In all these cases, the output signals are converted into a voltage signal, because
the voltage signal can be processed easily and can be given to analog to digital
converters or other signal processing circuitry for the post processing. So, the final
aim of the research in this project is to develop a novel general biosensor interface
bus that we named GBIB (Generic Bio-Interface Bus) with a standard interface
that supports as many types of biosensors as possible. Such platform can be very
useful, as during the design of a biosensor, the designers will only need to develop
the biosensor specific parts such as bioreceptor, transducer and a circuit that con-
verts the output signal into a voltage signal. Then the GBIB platform can be used
for the rest of the stages.
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6.2 Project Analysis
Depending on the types of biosensors, there can be different requirements on the
system in terms of performance, signal processing channels, processing time, etc.
So, the GBIB system should be flexible, programmable and easy to use. Besides
the development of the general purpose platform, it is also necessary to validate
it by interfacing with biosensors that may contain bioreceptors, transducers and
signal conversion circuitry. The development involves in hardware, firmware and
software. The hardware design includes designing the GBIB and biosensor specific
hardware. So, the design follows hardware/software design methodology in order
to optimize the coordination between different designs. With this design approach,
different designs can go in parallel and overall design time can be reduced.
6.3 Model Implementation
In this model the hardware design and software design are implemented in
parallel and this section includes all the design steps that are carried out during
the development.
6.3.1 Requirements
The requirements are the first step in the design steps and they include both
functional and non-functional requirements.
The functional requirements are following:
• The GBIB system should contain a connection interface for biosensor specific
circuitry.
• The GBIB system should contain a graphical user interface for controlling a
test or for visualizing measurement results.
• The GBIB system should contain signal processing blocks.
• The GBIB system should contain data processing blocks.
• The GBIB system should also support applications that need digital signals.
• The GBIB system should contain at least 4 voltage signal generation blocks.
• The GBIB system should contain at least 4 current signal generation blocks.
• The GBIB system should support at least 16 biosensor measurement channels.
• The GBIB system should contain a connector that is used for interconnection.
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• The GBIB system should contain a programming interface for updating in-
ternal firmware.
• An electrochemical sensor specific system would be required to test the inter-
connectivity with the GBIB system.
• The electrochemical sensor specific system should contain 3 measurement
channels.
• An ion-sensitive biosensor specific system would be required to test the inter-
connectivity with the GBIB system.
• The ion-sensitive biosensor specific system should contain 10 measurement
channels for ion detection and one channel for temperature measurement.
• A memristive biosensor specific system would be required to test the inter-
connectivity with the GBIB system.
• The memristive biosensor specific system should support at least 12 memris-
tive biosensor connection.
The non-functional requirements are following:
• The GBIB system should have high performance to support possible real-time
applications.
• The GBIB system should consume low power.
• The GBIB system should be portable, should have moderate dimensions and
weight.
• The GBIB system should help the designer to lower the design costs.
6.3.2 Specification
The specification is the bridge between the requirements and architecture. It
describes what the system should do. In this project the specifications are described
as following: the GBIB system shall communicate with other biosensor specific sys-
tems through its connection interface. The connection interface will power up the
biosensor specific systems, provide biosensor specific systems with required voltage
or current stimulation signals or other types of digital signals. This connection
interface will accept the incoming voltage signals from these biosensor specific sys-
tems. The connection interface will read some information from these biosensor
specific systems when needed. The GBIB system will process the incoming voltage
signal and convert it to digital signal. Then the system will process the digital
signal and visualize it or transmit it to external servers wirelessly.
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The biosensor specific systems will connect to GBIB system for accepting the stim-
ulation or excitation signals through the general connection interface. These sys-
tems shall convert the output signals from bioreceptors into the voltage signals
and provide the signals to the GBIB system for a signal measurement. In order
to guarantee the compatibility with the general connection interface on the GBIB
system, the biosensor specific systems should contain a specific interface driver for
the connection.
6.3.3 Architecture
The architecture design contains two parts: hardware and software. The hard-
ware includes the hardware functional blocks, while the software corresponds to
the software functional blocks. The architecture design describes how the system
implements the requirements and specifications described earlier. In order to do
that, the system would need both hardware and software blocks.
Hardware Architecture
In the hardware of the GBIB system, possible hardware blocks are: GBIB
control and data processing blocks. The GBIB control block contains the blocks
related to the measurement and generation of signals, general connection interface
to biosensor specific systems, data processing blocks, and data logging or trans-
mission blocks. Besides that, there is also the interface driver that connects the
biosensor specific systems to the GBIB system. A simplified hardware architec-
ture that includes both GBIB system and biosensor specific systems is presented
in Figure 6.2. As it can be seen from the Figure 6.2, the simplified architecture
contains the GBIB interface that connects the biosensor specific systems, called
electronic biosensor to the GBIB system. The central control block processes the
data and commands, controls the other hardware and communicates with the post
processing block. The sensing and actuation block generates voltage and current
signals and it also measures the incoming voltage signals. In the post processing
block, the cloud IoT interface can be useful for Internet of Things (IoT) applica-
tions, while the smart data analysis processes and visualizes the data coming from
the serialport communication in the GBIB Control block.
In the electronic biosensor block, the interface driver is dedicated to the connection
with GBIB System. The sensor front end transduces the biological or electrochem-
ical signals coming from the biosensor block into voltage signals.
A more detailed hardware architecture is shown in Figure 6.3. In the central control
block, besides the micro-controller that processes the data and commands, there is
the voltage regulator block that supplies the whole system with a stable operating
voltage. There is also the humidity and temperature sensor module that is used to
measure the humidity and temperature of the experimental environment.
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Figure 6.2: Simplified hardware architecture of the overall system
In the sensing and actuation block, the voltage signals are generated from Digital
to Analog Converter (DAC) block, while the current signals are generated from the
current generator block. The measurement of the signal is done by the Analog to
Digital Converter (ADC) block.
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Figure 6.3: Detailed hardware architecture of the GBIB Platform
The GBIB interface block is dedicated to the interconnection with electronic biosen-
sors and it contains a header with 26 pins.
The serialport and storage block enables the possibility of storing measurement
data on local µSD Card or transfers the data to post processing block through a
serial port.
In the interface driver block, the 26 pin header block is dedicated to the intercon-
nection with GBIB board. The SPI Flash memory block is used for storing the test
parameters of the electronic biosensor. The multiplexer block enables the possibil-
ity of selecting between 16 different voltage signals coming from the sensor frond
end block.
The sensor front end block conditions the signals from the transducers, converts to
voltage signals and forwards them to the multiplexer input.
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Software Architecture
In the software architecture, the software blocks carry out different operations
required by the system. According to the previously mentioned requirements and
specifications, a possible software architecture can be following as shown in 6.4.
In this architecture, the Graphical User Interface provides the user the possibil-
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I2C UART
Could IoT
UART
SPI
I2C
SPI
Figure 6.4: Software architecture of the GBIB system
ity of controlling the whole system, graphically analyzing or visualizing the data.
The central control block executes the commands coming from the GUI and also
other operations needed to guarantee a safe software working environment. It con-
trols the Mux and ADC block and retrieves measurement results from the ADC.
The central control block also controls the DAC block via SPI interface and gen-
erates excitation signals by writing digital samples into the DAC. It can also read
the environmental temperature and humidity from the H&T sensor module. The
timer block is responsible for generating interrupt signals and carrying out periodic
operations. It is also controlled by the central control block.
6.3.4 Components Design
In this section, the previously mentioned hardware and software architectures
are implemented in actual hardware and required components are selected in this
step. In this section, each of the hardware and software block is analyzed and a
corresponding hardware component or setup is designed or selected.
Hardware Components Design
A) GBIB Interface. The GBIB interface is composed of a 26-pin female
header and it is used for communicating with the Interface Driver (ID) in the elec-
tronic biosensor. In the Figure 6.5, the detailed information on each pin is shown:
The GBIB Interface contains voltage supply lines of ±3.3 V, ±5 V, and a ground
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Figure 6.5: GBIB Interface pinout
line. These voltage levels are commonly seen in biosensing applications. There
are also 4 SPI connection lines for communicating with the flash memory inside
the electronic biosensor. For some biosensing applications, clock signals would be
required, so two clock lines are included. The ADC block inside the sensing and
actuation block has a single ADC input. So, one line is dedicated for connecting
external voltage signal to the input of the ADC. There are 4 voltage signal lines and
4 current signal lines for applications that need excitation or stimulation signals.
Other two wires are used for dynamically detecting external electronic biosensors
when they are connected to the GBIB interface.
B) Central Control. For processing the data and commands, the central con-
trol block uses the high performance STM32F769BGT6 micro-controller (µC). The
STM32F769BGT6 µC has a 216 MHz clock frequency, contains plenty of internal
hardware resources, and supports low power applications. For applications that re-
quire the humidity and temperature of the surrounding environment, the Adafruit
SHT31-D module is selected. this module has ±0.3◦C accuracy and ±2% relative
humidity.
C) Sensing and Actuation. An internal structure of the sensing and actua-
tion block is shown in Figure 6.6. The ADC block contains the 24-bit LTC2380-24
ADC and this ADC chip has a very high accuracy. It has a single input channel
and it can support upto 1.5Msps/2Msps sampling frequency. It also consumes very
low power. The DAC block is based on a 16-bit AD5686R and this DAC has 4
output channels. The current generator block can generate 4 different ranges of
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current signals: 0 to 1 nA, 0 to 100 nA, 0 to 100 µA and 0 to 25 mA. This block
contains a AD5686R chip and several voltage to current conversion circuits.
LTC2380-24
ADC 
AD5686R 
DAC 
V-to-I
Conversion
Single to 
Differential
Conversion 
AD5686R 
DAC 
Vin
Vout
Iout
SPI
SPI
SPI
Figure 6.6: Sensing and Actuation.
In the current generator block, there are the DAC that generates voltage signals
and a voltage to current conversion block. The schematics of the voltage to current
conversion block is shown in Figure 6.7.
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Figure 6.7: Schematics of the bipolar voltage to current converter
In this circuit, the 60812fd chip is used and it contains 4 operational amplifiers.
Here the relationship between the output current and input voltage is following:
Iout =
Vin
1000×R7 . (6.1)
So, if the input voltage is in the range of ±2.5 V and R7 is 25 Ω, then the output
current is in the range of ±100 µA. By changing the value of R7, it is possible to
obtain the different current ranges mentioned earlier.
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D) Serialport and Storage. After the measurement results are processed
by the STM32F769BGT6 µC, it is needed to transfer the data to post processing
blocks. So, a uart-to-serial conversion block is needed in the GBIB control block
for the serial port communication. This conversion block is based on FT232RL
chip. Besides sending the measurement results to other blocks, some applications
may require data logging into a µSD Card. In this case, it is necessary to have a
µSD Card slot in the system.
E) Post Processing Block. This block is responsible for the post processing
of data and analyzing the results. Some applications require high performance pro-
cessors for real-time processing. So, the Raspberry Pi (RPi) 3 Model B embedded
computer is selected for this purpose. It has a high frequency Quad-core GPUs for
carrying out complex tasks and calculations during the data analysis. The RPi also
contains an integrated WiFi module, so it supports IoT and Cloud based applica-
tions. Besides that, it has the Raspbian Operating System (OS) running inside and
it supports the development of software applications.
F) Interface Driver. The interface driver bridges the electronic biosensor with
the GBIB board through the GBIB connector. During the design of the interface
driver, the W25Q80JVSNIQ SPI-Flash memory is used for storing test parameters
and information related to the biosensor. The CD74HC4067SM96 chip is selected
due to its very low switching time and on-state resistance.
Software Components Design
In this section, the implementation of the software blocks run inside the STM32F769BGT6
Micro-controller and RPi are described.
A) GUI. Inside the Raspbian OS of the RPi, it is possible to develop soft-
ware applications using the Qt Creator programming environment. So, a GUI is
developed in C++ for controlling the GBIB system and also for the post process-
ing and visualization of the data coming from GBIB system as depicted in Figure
6.8. In the GUI, there are three types of measurement options: Electrochemistry
for the test with Electrochemical Electronic Biosensors, Voltage Sweep for Memris-
tive Electronic Biosensors and Open Circuit Potential for ion-sensitive Electronic
Biosensors.
The Electrochemistry option allows electrochemical techniques such as CA, CV and
DPV along with the test parameters. The Voltage Sweep panel provides options for
setting up test parameters for the Memristive biosensors. The OCP panel provides
the options for selecting the input channels and carrying out the sampling of the
signals.
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Figure 6.8: GUI for controlling the whole system
B) Central Control. All the hardware and software inside the micro-controller
are initialized by the central control block. Then after the initialization, the cen-
tral control enters the continuous while loop and checks the serialport to see if
there is any command arrived from the GUI. When on the GUI side the exper-
iment type, its relevant parameters are selected and sent to the central control
over the serialport, then the central control will extract all the information, setup
the timer and DAC blocks and then carries out the measurements. Here the timer
library controls all the measurement flags and also when to write to the DAC block.
C) DAC. The DAC library is used to write to the DAC and generate a volt-
age signal. The generated voltage ranges from 0 to 2.5 V, then after the doubling
circuit, the final output voltage will be in the range of 0 to 5 V. The relationship
between the digital value and actually generated voltage at the output of the DAC
chip is following:
Vout =
D
65535 × 2.5(V ). (6.2)
Thanks to the timer library, it is possible to control the digital value very precisely
and the desired output voltage shape can be generated at the output of the actual
DAC chip.
D) Mux & ADC. By writing to the GPIO pins of the micro-controller, it is
possible to control the multiplexer located inside the interface driver of the elec-
tronic biosensor and the desired voltage channel can be selected for the sampling.
Once the multiplexer selects which channel to read, the ADC block will carry out
sampling of the voltage signal and the output results will be read by the central
block through the SPI port. The output results have 24 bits and the input voltage
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can be calculated through the following equation:
V in = (Output_code2N )× VREF . (6.3)
In our case, the N is equal to 24, the VREF is 5 V.
E) Data Processing. In this block, the data processing and visualization takes
place. it is implemented as a part of the GUI application. The data processing
is different according to the type of measurements, as in some cases, the input
electrical signal at the sensor front end is a current signal and in other cases it can
be a voltage signal or other types of electrical signals. This is dependent on the
actual application.
6.3.5 System Integration
After the hardware and software components are complete, the next step is to
integrate them and carry out relevant tests. Figure 6.9 shows the first prototype of
the GBIB Platform plus 3 electronic biosensors. The electronic biosensors can be
GBIB Platform
Electronic
Biosensors
Interface 
Driver
A
B
C
D
Figure 6.9: First prototype of the system. A) amperometric biosensors B) Ion-
Sensitive biosensors C) Memristive biosensors D) GBIB Platform
connected to the GBIB platform through the 26-pin flat cable and relevant tests can
be performed by configuring the GBIB platform through the GUI inside the RPi.
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The next step is to carry out experiments with the GBIB platform and electronic
biosensors.
6.4 Experimental Results
6.4.1 Electrochemical Sensor Experiment
To verify the performance of the GBIB with the amperometric electrochemical
sensing platform (intended as sensor connected to frontend and interface driver),
we have carried out a 6-point CV calibration of Paracetamol (APAP) drug in Phos-
phate Buffered Saline (PBS) as background electrolyte. A staircase voltage between
-0.1 V and 1.1 V have been applied on the electrochemical cell by the GBIB system
and a current, proportional to APAP concentration in solution, have been measured
back by the system. The calibration line obtained by the six increasing APAP con-
centrations measurements was compared with the calibration line obtained by a
commercial instrument, a Metrohm Autolab system (PGSTAT 302N), in the same
conditions. As shown in Figure 6.10, the two calibration lines are highly compa-
rable, and the GBIB system results to have an higher sensitivity respect to the
commercial Autolab (1× 10−7A/µM vs. 5× 10−8A/µM). Therefore, we confirmed
the efficacy of GBIB with the Electrochemical Biosensor Board.
6.4.2 Ion-Sensitive Biosensor Experiment
Potentiometric experiments were carried out to prove the efficacy of our GBIB
board in combination with the Ion-sensitive Biosensor Board (Figure 6.9.B). Pre-
viously developed [87] all-solid state ion-selective sensors based on nanostructured
platinum contacts were used for this purpose. The results are reported in Figure
6.11 in comparison with a commercial Autolab potentiostat (Metrohm, Switzer-
land). It is possible to observe that in both cases very smooth and stable responses
are obtained with quasi-nernstian slope. From the small insets showing the time
trace during successive solute additions, it is evident that the proposed electronic
device offers sharper steps, with lower potential drift especially at high concentra-
tions. In addition, a slightly lower Limit of Detection (LOD) is achieved with the
GBIB system with respect to the commercial one (8.5× 10−6M vs. 1.3× 10−5M).
6.4.3 Memristive Biosensor Experiment
One of the most important features in the electrical response of the memristive
devices is the characteristic hysteresis loop. The memory effect can be attributed
to the rearrangement of the charge carriers at the nanoscale due to external per-
turbation like the applied voltage bias. For most of the bare nanowire devices this
hysteresis appears fully pinched at zero voltage or almost pinched at very close
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Figure 6.10: A) CV acquisition from GBIB system B) CV acquisition from Autolab
C) Comparison of calibration lines obtained for CV measurements of six increasing
concentrations of APAP (50;100;150;200;250;300) µM
.
to zero voltage values due to the impact of environmental conditions, such as the
ambient humidity. While, usually, the fully-pinched hysteresis is then lost during
bio-detection. Figure 6.12 shows acquisitions done with our boards as compared
with previously designed Memristive Biosensing System [78].
As it can be seen from Figure 6.12.B, the measurement is carried out successfully
by using the Memristive Electronic Biosensor Board (Figure 6.9.C) together with
the GBIB Platform. However, the fully-pinched hysteresis is not present unlike
the one in Figure 6.12.A. The Memristive Electronic Biosensor board is designed
as a two-layer PCB and since the measured current is in the picoAmpere range,
the noise contribution is too much. But this can be addressed by designing the
board with a 4 or more layer with proper PCB layout and most importantly, the
interfacing between the Memristive Electronic Biosensor Board and GBIB Platform
is successful and all the blocks in the GBIB Platform and the interface driver have
operational as expected.
Therefore, from the experimental results, we can confirm that the demonstrator
can successfully interface with the three different electronic biosensors.
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Figure 6.11: Comparison of lithium ion detection with a commercial Autolab po-
tentiostat (A) and with our GBIB system (B). The small insets show the time trace
during successive solute additions, while the main graphs display the corresponding
calibration curves.
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Figure 6.12: Comparison of voltage gaps on bare memristive nanowires between
A) Memristive Biosensing System [78] and B) Memristive Electronic Biosensor
(Figure 6.9.C).
6.5 Conclusion
From the experimental results, we can conclude that the GBIB Approach works
for solving the problem of interconnection between different biosensing platforms
and biosensors. It was validated the general purpose of the GBIB system by inter-
facing it with three different electronic biosensors and proving its efficacy in per-
forming high-performance measurements. The main advantages and performances
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of this GBIB Platform are:
1) having a unique protocol to interface all kind of electronic biosensors;
2) providing a standard for biosensors future developments;
3) assuring a strict co-design for advanced bio/CMOS interface in molecular detec-
tion.
The design of the whole system has strictly followed the hardware/software de-
sign methodology and the different design sections are implemented in parallel.
The functionality of the system is also verified through the experimental step and
this is the very first general purpose embedded system for electronic biosensors.
Furthermore, the system is smart in a way that it can detect automatically the
connected electronic biosensor board, extract the board information and provide
initial test parameters relevant to the board from GUI control panel.
In future works, a further validation with memristive electronic biosensor board
(Figure 6.9.C) will be carried out after the optimization phase of the board. The
implementation of artificial intelligence algorithms, e.g., by exploiting Deep Learn-
ing architectures, will be further implemented in the RPi in order to further improve
the performances as well as the self-autonomy of the general sensing system as a
global and autonomous acquiring system. Besides that, the GBIB Platform will be
designed as a multilayer PCB with proper shielding in order to reduce the noise
and electromagnetic interference.
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Chapter 7
Conclusion and Future Work
The overall objective of the thesis was to apply the embedded system design
methodologies in real-world biomedical applications. Design methodologies were
applied in five different complex projects in order to validate the design approach
and to provide a guideline on how to design an embedded system for a given appli-
cation. This is very important, because the applications can be very different, but
the idea behind how to proceed with the design of an embedded is generally the
same. The importance and advantages of the design methodologies are confirmed
through different embedded system design use cases mentioned in previous chapters
(Chapter Two to Chapter Six).
Main achievements
The major achievement in this thesis is to demonstrate how to choose a proper
design methodology, implement it and come out with a successful design of an em-
bedded. The selection of the design methodology is very important for numerous
reasons mentioned in the Chapter One. The thesis analyzes the possible reasons
and situations for selecting a design methodology and this can be greatly useful for
designers during the design of an embedded system.
During the development of the electrical and mechanical stimulation and monitor-
ing system for cell differentiation in Chapter Two and the wearable sEMG system in
Chapter Three, the successive refinement method is used for the following reasons:
• In both applications, there is not enough information regarding the biological
impacts and the output behaviour of the embedded system, so the designed
system might not work as expected in a first round. Therefore, the design
concepts and technology have to be tested through the first prototype of the
system and then are gradually refined and improved.
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• Additional requirements and features need to be added after the first proto-
type.
• The target application requires continuous improvement and updates on the
embedded system.
• Multiple design cycles are supported by the target application in terms of
cost and design time.
In these two projects, some of the ready-to-use components are selected in order to
reduce the design efforts. For example, the embedded system for the cell stimulation
is based on Raspberry Pi 3. The central node of the sEMG system is based on
nRF52 development board, while the measurement nodes are custom designed.
During the development of the drug monitoring system in Chapter Three, the
memristive biosensing platform in Chapter Four and the general purpose interface
bus system in Chapter Five, the hardwaresoftware design method is used. The
reasons are following:
• These systems are complex and they can be split into sub-blocks for parallel
design.
• There is a strict constraint on the design time of the system.
• There is relatively enough information regarding the expected functionality
and behaviour system.
• Design techniques and hardware architectures are relatively mature and no
additional design cycles are required.
• There are enough design teams available.
In contrast, a designer can consider using the waterfall model in the following cases:
• The requirements and specifications of the system are clear,well documented
and fixed.
• Technology is well understood and is not dynamic.
• Product definition is stable.
• No ambiguous requirements are present.
• Enough resources and design expertise are available to support the product.
• The project is relatively short.
While the spiral model can be considered in following situations:
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• When the project is very large and is a medium to high-risk project.
• When the target application allows to create a prototype.
• When the risk and cost evaluation is important.
• When the requirements and specifications are complex and unclear.
• When changes may be required at any time.
• When there is a need to frequently release a product.
• When long-term commitment of the project is not feasible and continuous
evaluation of the project is required.
After the selection of a design methodology, it is preferable to choose ready-to-use
components or modules whenever they are available and meet the requirements of
the target project. This is important because it can help reduce the design efforts,
cost and time. If no ready-to-use components or modules are available, then one
can design his custom component or module. In this case, it would be preferable
to design a reusable module, so that the same custom platform or module can be
adopted for other applications as a ready-to-use block.
Further achievements
Further achievements in this thesis are the successful development and validation of
novel embedded systems for five different biomedical applications and the scientific
impacts and innovative contributions of these systems are summarized below.
• High performance electrical and mechanical cell stimulation and
monitoring system. The aim of this design is to develop a robust, easy to
use bio-reactor system that is capable of generating electrical and mechanical
stimulation signals and monitoring in real-time the effects of the stimulation
process. The system is intended to be used for stem cell differentiation in
tissue engineering. The system is described in details in Chapter Two.
The hardware of the system is flexible and most of the components are con-
nected in plug-and-play manner in the system so that individual parts can be
easily replaced for upgrades. It has independent signal generation units that
can generate electrical or mechanical stimulation signals with high accuracy
and it is confirmed by observing the electrical outputs of the stimulation units
through an oscilloscope.
Development of such system is extremely important, as it can provide an ideal
platform that can provide proper physiological conditions to the stem cells
and differentiate them into the proper organs or tissues that are required.
After the bioreactor system is complete, it is used for tendon regeneration
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experiment. The cell cultures are mechanically stimulated in a bioreactor
showing the positive role of the tested dynamic culture condition on cell
alignment and tenogenic differentiation. The synergistic effect of mechanical
stimulation results in an enhancement of cell adhesion, proliferation, align-
ment, and differentiation, illustrating the potential of the bioreactor system
for tendon tissue engineering. These results provide insight on selection of
proper culture conditions for engineering highly organized and biomimetic
tendon tissues. In addition, the proposed multi-layered constructs in which
each compartment can be independently tailored paves the way for engineer-
ing tissue-like constructs with suitable mechanical properties at both tissue
and cell levels [23].
• Ultra low-power wearable wireless surface EMG system. In reha-
bilitation therapy, it is often necessary to carry out long-term continuous
monitoring of the muscle activities of the patients. Therefore, the clinicians
would need a system that could carry out long-term monitoring. But the
commercially available devices could not support the long term monitoring
due to their battery life, so a low-power wearable long term monitoring sys-
tem is designed and testes for this application. The system is described in
details in Chapter Three.
The experiments indicate that the designed system can operate in wireless
transmission mode where the acquired data are transmitted in real-time via
custom wireless communication as well as in offline mode where the data are
stored into a local µSD Card. Dynamic configuration of the wireless radio
protocol ensures safety of the data packets, reliability and robustness in the
communication. In each working mode, three acquisition techniques are sup-
ported, such as raw surface EMG data acquisition, envelope data acquisition
and Adaptive Threshold Crossing. Most importantly, the optimized hard-
ware and software design enables the system to consume very low power and
a long-term monitoring of 32 to 61 hours is possible under a 450 mAh coin
battery.
The 10 µs synchronization accuracy is achieved among multiple measurement
nodes and up to 100 nodes are supported by the system thanks to the dynamic
frequency hopping technique integrated into the system. Optimized area and
reduced cost give the system more advantages in going to the market.
Future work in this application can be to investigate the possibility of auto-
matic muscle synergy extraction and real-time display. This can be very useful
as it will provide a direct information on the muscle under the measurement.
The area of the system could be optimized by applying multi-stack architec-
ture and the quality of the signals can be improved by multi-layer PCB design
and by proper shielding.
• Multi-channel electrochemical biosensing platform. In drug delivery,
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there are many potential risks and challenges regarding the effects of a drug
in a patient as its effect changes with the physical status of the patient, his
living environment and health status. Therefore, it is very critical to ensure
a correct delivery of a drug to the patient. The designed three-channel elec-
trochemical biosensing platform is dedicated to continuous monitoring and
delivery of anesthesia in surgeries or Intensive Care Units. Such platform
is very important in tracking the mount of anesthesia in patient blood and
delivering the right amount of dosage to the patient. The system is described
in details in Chapter Four.
Experimental results confirm that the designed biosensing platform is capable
of monitoring the anesthesia compounds, such as Paracetamol and Propofol.
Through the experiments, it is also confirmed that each measurement channel
is able to carry out electrochemical techniques such as ChronoAmperometry
(CA), Cyclic Voltammetry (CV) and Differential Pulse Voltammetry (DPV)
for the detection of paracetamol and propofol.
The test results also confirm that the system has better performances and
several advantages compared to the commercial Autolab potentiostat pro-
duced by Metrohm PGSTAT302N. The designed system has very low cost,
simultaneous detecting capability of several drugs and temperature and pH,
high portability and small dimension (27 × 21 × 13 cm). Integrated WiFi
module in the system has made it possible to remotely access the system for
monitoring the status of the patients, for keeping control over the monitored
parameters and controlling the drug delivery remotely.
Further tests are carried out in the undiluted human serum medium and the
system is able to detect paracetamol and propofol in such medium. This is
the first ever successful simultaneous detection of these compounds in human
serum that has lasted over 24 minutes [44]. Besides that, the multiple mea-
surement channels in the system make it possible to be used for multiplexed
drug monitoring applications.
• Portable point-of-care memristive biosensing platform. Cancer is one
of the main causes for many deaths every year and researchers are studying
cancer extensively in order to diagnose it in early stage and apply some cures
to the patient. The early stage cancer diagnostics is very crucial and impor-
tant, because if the cancer is detected in its early stage, then there would be
the possibility to stop or at slow down its evolution.
The memristive biosensors proved to be excellent candidates in detection of
cancer and other molecules thanks to their ultrahigh sensitivity. However,
the memristive biosensors need to be integrated with electronics and for that
reason, a portable, low cost and low power embedded biosensing platform is
developed. The system is described in details in Chapter Five. Experimen-
tal results confirm the advantages of the biosensing platform compared to
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the previously used commercial probe stations and parameter analyzers for
memristive biosensors. The results confirm that the system is able to carry
out measurements in a relatively short time, such as couple of seconds with
respect to 40 minutes in the case of commercial probe stations and parameter
analyzers. The small area, low cost, low power consumption, portability and
programmability makes the system more preferable compared to industrial
instruments in cancer detection related research. The disposable memristive
biosensing chips enable the system to perform various independent clinical
tests on different patients. In the next steps, multi-panel detection property
will be investigated by automatic antibody spotting machine. This enables
the printing of multiple types (up to 12 types) of antibodies on a single mem-
ristive biosensing chip and this paves the way for a simultaneous detection of
several diseases through a single measurement.
With the designed system we have achieved the first ever detection of immune
attacks at an ultra-high sensitivity as few as six cancer marker molecules in
a five micrometers section of breast tumor tissue. This is a technological
breakthrough in the momentum of breast cancer immunotherapy and it has
tremendous potential for guiding precision oncology. The relevant results are
submitted to the Science Advances Journal.
• General purpose biosensing interface bus system for biosensors.
Biosensors have the property of selectivity and the electronic systems that
are designed so far are biosensor specific. This means that one electronic sys-
tem for one type of biosensor could not be used for another type of biosensor
as they are customized for the biosensor of interest. In this application, a
novel, general purpose embedded system is developed in order to provide a
standard connection interface that can be supported by any types of biosen-
sors with proper interface driver and signal conversion units. The system is
described in details in Chapter Six.
Designing such system is very important as it addresses the incompatibility
between electronic platforms and biosensors. It also provides a ready-to-use
electronic system that can be used to interface with the biosensor and to
reduce the overall design time and cost in the development of a complete
biosensing platform. The system is capable of producing highly precise volt-
age and current signals and can carry out high-speed data processing.
Experimental results on electrochemical biosensors show that the general pur-
pose platform can be interfaced with electrochemical electronic biosensors and
carry out electrochemical tests, such as Cyclic Voltammetry in this case. The
results on ion-sensitive biosensors show that the general platform is also able
to be used with electronic biosensors that are dedicated to open circuit poten-
tial measurement. The different experiments are selected and configured on
the graphical user interface inside the system. The successful results indicate
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the robustness, flexibility of the graphical user interface.
More importantly, these test results on different biosensors using same gen-
eral platform paves the way to present a new design approach for advanced
bio/CMOS interfaces and a new concept in the definition of a biosensor.
The design of these embedded systems are the first stage of possible future inte-
grations and they are designed in direct cooperation with hospitals and specific
research institutes. This helps us collect useful information for passing to a second
stage to design integrated solutions with FPGAs or Integrated Circuits that are
ready to become medical devices.
Future Research Directions
Artificial Intelligence (AI) is gaining more attention in many areas, as well as in
bio-medical applications. By integrating the AI, an embedded system can become
’intelligent’, in the sense that it can perform analysis of data, images just like clin-
icians or doctors.
In the stem cell stimulation and monitoring system, the neural network algorithms
should be exploited to process real-time monitoring images and track the status
of the stimulation. The possible of generating ambient specific stimulation signals
should also be taken into account.
In the surface EMG system, a trained neural network may give the possibility of
real-time extraction of muscle synergies from surface EMG data.
In the memristive biosensing platform, AI algorithms can be incorporated into the
system in order to obtain directly the actual status and relevant information of the
cancer or other diseases.
In the electrochemical biosensing platform for the anesthesia, the AI algorithms
may give the possibility of extracting some key values such as current peaks and
positions of the currents and this would reduce greatly the transmitted amount of
data during the measurement.
In the general purpose platform, an AI algorithm may give the possibility to au-
tomatically setup can carry out the experiment based on the connected electronic
biosensors and analyze the results in a smart way.
From the examples above, using AI in biomedical applications can have many ad-
vantages as listed in the examples above. Especially when there is a huge amount of
data to be processed or transmitted, an AI algorithm could be helpful in extracting
the useful results.
So, the future trend of my research would be to design AI based embedded systems
for biomedical applications using previously described design methodologies.
As a final conclusion, this thesis demonstrates how to apply embedded system de-
sign methodologies in various types of biomedical applications and validates the
design approach with experimental results.
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